US20060041218A1 - Designs for left ventricular conduit - Google Patents

Designs for left ventricular conduit Download PDF

Info

Publication number
US20060041218A1
US20060041218A1 US11/246,219 US24621905A US2006041218A1 US 20060041218 A1 US20060041218 A1 US 20060041218A1 US 24621905 A US24621905 A US 24621905A US 2006041218 A1 US2006041218 A1 US 2006041218A1
Authority
US
United States
Prior art keywords
implant
stent
configuration
conduit
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/246,219
Inventor
David Phelps
Greg Furnish
Todd Hall
Mark Griffin
Scott Wolf
Peter Wilk
Jay Schmelter
Simon Furnish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Percardia Inc
Original Assignee
Percardia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Percardia Inc filed Critical Percardia Inc
Priority to US11/246,219 priority Critical patent/US20060041218A1/en
Publication of US20060041218A1 publication Critical patent/US20060041218A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/3207Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2493Transmyocardial revascularisation [TMR] devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/94Stents retaining their form, i.e. not being deformable, after placement in the predetermined place
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22072Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other
    • A61B2017/22074Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other the instrument being only slidable in a channel, e.g. advancing optical fibre through a channel
    • A61B2017/22077Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other the instrument being only slidable in a channel, e.g. advancing optical fibre through a channel with a part piercing the tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/826Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents more than one stent being applied sequentially
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/005Rosette-shaped, e.g. star-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/006Y-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/902Method of implanting
    • Y10S623/903Blood vessel

Definitions

  • the present invention relates to an apparatus for bypassing a blocked blood vessel segment, and, more particularly, to a conduit or stent positioned between the coronary artery or other blocked vessel and a chamber of the heart, such as the left ventricle of the heart, to bypass a blocked segment of the coronary artery or other blood vessel.
  • Coronary artery disease is a major problem in the U.S. and throughout the world. Coronary arteries as well as other blood vessels frequently become clogged with plaque, which at the very least impairs the efficiency of the heart's pumping action, and can lead to heart attack and death. In some cases, these arteries can be unblocked through noninvasive techniques such as balloon angioplasty. In more difficult cases, a bypass of the blocked vessel is necessary.
  • one or more venous segments are inserted between the aorta and the coronary artery.
  • the inserted venous segments or transplants act as a bypass of the blocked portion of the coronary artery and thus provide for a free or unobstructed flow of blood to the heart. More than 500,000 bypass procedures are performed in the U.S. every year.
  • Such coronary artery bypass surgery is a very intrusive procedure that is expensive, time-consuming and traumatic to the patient.
  • the operation requires an incision through the patient's sternum (sternotomy), and that the patient be placed on a bypass pump so that the heart can be operated on while not beating.
  • a vein graft is harvested from the patient's leg, another highly invasive procedure, and a delicate surgical procedure is required to piece the bypass graft to the coronary artery (anastomosis). Hospital stays subsequent to the surgery and convalescence are prolonged.
  • PTCA percutaneous transluminal coronary angioplasty
  • vascular treatments are not always indicated due to the type or location of the blockage, or due to the risk of emboli.
  • the preferred embodiments of the present invention address the need in the previous technology by providing a bypass system that avoids the sternotomy and other intrusive procedures normally associated with coronary bypass surgery. These embodiments also free the surgeon from the multiple anastomoses necessary in the current process.
  • the preferred device provides a shunt for diverting blood directly from a chamber in the heart, such as the left ventricle, to the coronary artery, distal to the blockage, therefore bypassing the blocked portion of the vessel.
  • the shunt comprises a stent or conduit adapted to be positioned in the heart wall or myocardium between the left ventricle and the coronary artery that allows for the direct passage of blood therethrough.
  • the terms “stent” and “conduit” are interchangeable, and refer to a device that allows for the passage of blood therethrough.
  • myocardium and “heart wall” are also used interchangeably.
  • the conduit described herein can be used to provide a passageway for the flow of blood from any heart chamber, not only the left ventricle.
  • the stent device is delivered either externally or internally through the coronary artery to a position distal to the blockage. At that position, the coronary artery, the myocardium and the wall of the left ventricle are pierced to provide a channel completely through from the coronary artery to the left ventricle of the heart. The stent is then positioned in the channel to provide a permanent passage for blood to flow between the left ventricle of the heart and the coronary artery, distal to the blockage.
  • the stent is sized so that one open end is positioned within the coronary artery, while the other open end is positioned in the left ventricle.
  • the hollow lumen of the stent provides a passage for the flow of blood.
  • the stent can be self-expandable or expanded by means of a balloon or similar device, and can be provided with various means to anchor it in position within the myocardium, such as expandable legs, hooks, barbs, collars, suture holes and the like.
  • the stent can be formed from a plurality of rings, which can be connected to provide stability.
  • the stent can include a valve in its interior, and can also be used to deliver drugs or other pharmaceutical compounds directly into the myocardium and the coronary circulation.
  • FIG. 1A is a cross-sectional view of a human heart, aorta and coronary artery.
  • FIG. 1B is a side view of one embodiment of an expandable stent and the balloon catheter used for stent delivery.
  • FIG. 2 is a side view of the stent of FIG. 1B mounted on the distal end of the catheter for delivery into the myocardium, with the coronary artery and myocardium shown cut-away.
  • FIG. 3 is a side view of the distal end of the stent/catheter assembly of FIG. 1B positioned in the myocardium, with the coronary artery and myocardium shown cut-away.
  • FIG. 4 is a cross-sectional side view of the stent of FIG. 1B positioned within the myocardium after removal of the catheter used for delivery.
  • FIG. 5 is a side view of another embodiment of the stent and the catheter used for stent delivery.
  • FIG. 6 is a cross-sectional side view of the catheter and puncture device used to introduce the self-expanding stent of FIG. 5 into the myocardium.
  • FIG. 7 is a cross-sectional side view of the stent/catheter assembly of FIG. 5 positioned in the myocardium.
  • FIG. 8 is a side view of the self-expanding stent of FIG. 5 positioned within the myocardium after removal of the catheter and puncture device, with the coronary artery and myocardium shown cut-away.
  • FIG. 9 is a perspective view of another embodiment of the stent having expandable legs, showing the stent mounted on the distal end of the introducer catheter.
  • FIG. 10 is a perspective view of the stent of FIG. 9 , showing the distal end of the introducer catheter pushed forward to allow the legs of the stent to expand.
  • FIG. 11 is a perspective view of the stent of FIG. 9 , showing the legs of the stent in an expanded position.
  • FIG. 12 is a side view of another embodiment of the stent positioned within the myocardium, with the coronary artery and myocardium shown cut-away.
  • FIG. 13 is a side view of a biodegradable stent positioned within the myocardium, with the coronary artery and myocardium shown cut-away.
  • FIG. 14 is a side view of a catheter and puncture device used to introduce a bulkhead stent into the myocardium, with the coronary artery and myocardium shown cut-away.
  • FIG. 15 is a side view of the stent/catheter assembly of FIG. 14 positioned in the myocardium, with the coronary artery and myocardium shown cutaway.
  • FIGS. 16-19 are progressive side views of the stent/catheter assembly of FIG. 14 , showing the bulkhead stent being deployed into the myocardium.
  • FIGS. 20 and 21 are enlarged views of FIGS. 18 and 19 , respectively, showing the bulkhead stent being deployed into the myocardium.
  • FIG. 22 is a perspective view of a ring of a bulkhead stent in a loaded configuration
  • FIG. 23 is a perspective view of a ring of a bulkhead stent in an inserted configuration.
  • FIG. 24 is a perspective view of a bulkhead stent within a delivery catheter, showing the rings of the bulkhead stent being inserted.
  • FIG. 25 is a perspective view of a bulkhead stent, with the rings of the stent in loaded and inserted configurations.
  • FIG. 26 is a perspective view of an inserter device used to insert a bulkhead stent.
  • FIG. 27A is a schematic, cross-sectional view of the human heart, showing a catheter used to form a channel through the myocardium and into the left ventricle inserted into the coronary artery.
  • FIG. 27B is an enlarged view of the distal end of the catheter and the channel through the myocardium in FIG. 27A .
  • FIG. 28 is a schematic, cross-sectional view of a stent delivery catheter positioned inside the channel formed in the myocardium.
  • FIG. 29 is a schematic, partial cross-sectional view of a self-expanding spring stent being positioned in the channel formed in the myocardium.
  • FIG. 30 is a schematic, partial cross-sectional view of the self-expanding stent deployed within the myocardium.
  • FIG. 31 is a perspective view of another embodiment of a stent having retention members which maintain the position of the stent.
  • the coronary artery branches off the aorta and is positioned along the external surface of the heart wall.
  • the anatomy of the human heart is illustrated in FIG. 1A .
  • Oxygenated blood flows from the heart PH to the aorta AO, on to the rest of the body, some of the blood flowing into the coronary artery CA.
  • plaque builds up within the coronary artery CA, blocking the free flow of blood and causing complications ranging from mild angina to heart attack and death.
  • one embodiment of the present invention provides for the shunting of blood directly from the heart to a site in the coronary artery that is distal to the blockage.
  • a channel is formed through the wall of the coronary artery and the myocardium and into the left ventricle of the heart that lies beneath the coronary artery.
  • a stent or conduit is positioned in the passage to keep it open, and allow for the flow of oxygenated blood directly from the heart into the coronary artery.
  • conduit in the myocardium between the left ventricle and the coronary artery is described in detail below, this is merely exemplary and use of the conduit between other chambers of the heart and the coronary artery, and between blood vessels is also contemplated.
  • the principles of the present invention are not limited to left ventricular conduits, and include conduits for communicating bodily fluids from any space within a patient to another space within a patient, including any mammal.
  • fluid communication through the conduits is not limited to any particular direction of flow and can be antegrade or retrograde with respect to the normal flow of fluid.
  • the conduits may communicate between a bodily space and a vessel or from one vessel to another vessel (such as an artery to a vein or vice versa).
  • the conduits can reside in a single bodily space so as to communicate fluids from one portion of the space to another.
  • the conduits can be used to achieve a bypass within a single vessel, such as communicating blood from a proximal portion of an occluded coronary artery to a more distal portion of that same coronary artery.
  • the conduits and related methods can preferably traverse various intermediate destinations and are not limited to any particular flow sequence.
  • the conduit communicates from the left ventricle, through the myocardium, into the pericardial space, and then into the coronary artery.
  • other preferred embodiments are disclosed, including direct transmyocardial communication from a left ventricle, through the myocardium and into the coronary artery.
  • transmyocardial should not be narrowly construed in connection with the preferred fluid communication conduits, and other non-myocardial and even non-cardiac fluid communication are preferred as well.
  • the preferred conduits and related methods are capable of fluid communication through all such walls including, without limitation, the pericardium, epicardium, myocardium, endocardium, septum, etc.
  • bypass which is achieved with certain preferred embodiments and related methods is not limited to a complete bypass of bodily fluid flow, but can also include a partial bypass which advantageously supplements the normal bodily blood flow.
  • occlusions which are bypassed may be of a partial or complete nature, and therefore the terminology “bypass” or “occlusion” should not be construed to be limited to a complete bypass or a complete occlusion but can include partial bypass and partial occlusion as described.
  • conduits and related methods disclosed herein can also provide complete passages or partial passages through bodily tissues.
  • the conduits can comprise stents, shunts, or the like, and therefore provide a passageway or opening for bodily fluid such as blood.
  • the conduits are not necessarily stented or lined with a device but can comprise mere tunnels or openings formed in the tissues of the patient.
  • the conduits of the present invention preferably comprise both integral or one-piece conduits as well as plural sections joined together to form a continuous conduit.
  • the present conduits can be deployed in a variety of methods consistent with sound medical practice including vascular or surgical deliveries, including minimally invasive techniques.
  • various preferred embodiments of delivery rods and associated methods may be used.
  • the delivery rod is solid and trocar-like. It may be rigid or semi-rigid and capable of penetrating the tissues of the patient and thereby form the conduit, in whole or in part, for purposes of fluid communication.
  • the delivery rods may be hollow so as to form the conduits themselves (e.g., the conduits are preferably self-implanting or self-inserting) or have a conduit mounted thereon (e.g., the delivery rod is preferably withdrawn leaving the conduit installed).
  • the preferred conduit device and method for installation is preferably determined by appropriate patient indications in accordance with sound medical practices.
  • aortic insufficiency is the leakage of blood through the aortic valve, resulting in a backflow of blood into the left ventricle.
  • the heart compensates for the backflow of blood by pumping harder, resulting in hypertrophy (thickening of the heart muscle) and dilation of the left ventricle wall. Left untreated, heart failure can result.
  • hypertrophy thickening of the heart muscle
  • dilation of the left ventricle wall Left untreated, heart failure can result.
  • the heart valves are unable to prevent the backflow of blood. This too can result in heart failure.
  • one embodiment of the invention provides for the use of a conduit placed within the heart wall to improve the flow of oxygenated blood through the body.
  • FIG. 1B A first embodiment of the present invention is illustrated in FIG. 1B .
  • This embodiment is a balloon-expanded stent 10 .
  • the stent 10 is introduced as described below, using a high-pressure balloon catheter 12 to deploy the stent 10 once it is properly positioned in the myocardium MYO ( FIG. 2 ).
  • the balloon 14 is inflated to expand the stent 10 and open the conduit from the left ventricle LV into the coronary artery CA.
  • the stent 10 can include attachment mechanisms not limited to hooks, barbs, flanges, large collars, suture holes and/or other means to ensure a seal is created between the coronary artery CA and the wall of the myocardium MYO and to prevent the threat of stent 10 migration.
  • attachment mechanisms not limited to hooks, barbs, flanges, large collars, suture holes and/or other means to ensure a seal is created between the coronary artery CA and the wall of the myocardium MYO and to prevent the threat of stent 10 migration.
  • the remaining catheter assembly 12 is removed, leaving the stent 10 in place.
  • the stent 10 Upon deflating the balloon 14 , the stent 10 will remain open. Because of the shape of this stent 10 , a dumbbell shaped balloon 14 is preferably used to ensure proper expansion, as described below.
  • FIGS. 1B through 4 illustrate the introduction of the balloon-expanded stent 10 into the myocardial wall MYO.
  • FIG. 1B illustrates the stent 10 mounted over the balloon 14 on the distal end of the stent introducer catheter 12 .
  • FIG. 2 illustrates the stent introducer catheter 12 following the path created by a puncture wire 16 extending past the distal end of the introducer catheter 12 , and used to access the left ventricle LV through the coronary artery CA and myocardium MYO.
  • Further details regarding conduits and conduit delivery systems are described in copending patent applications entitled DELIVERY METHODS FOR LEFT VENTRICULAR CONDUIT, U.S. patent application Ser. No. 09/368,868, now U.S. Pat. No.
  • FIG. 3 illustrates the non-expanded stent 10 positioned inside the myocardial wall MYO prior to inflation of the balloon 14 .
  • FIG. 4 illustrates an expanded stent 10 in position, with the introducer catheter 12 removed. Because of the way the attachment mechanisms 18 expand on this stent 10 , a dumbbell shaped balloon 14 is preferably used to flare out the ends of the stent 10 . These flared edges 18 maintain the stent 10 in its proper position in the heart wall MYO and provide a seal between the coronary artery CA and the outer heart wall MYO.
  • the second embodiment of the stent or conduit incorporates a self-expanding stent 20 , illustrated in FIGS. 5-8 .
  • the stent 20 having a retaining sheath 26 to hold it in a non-expanded configuration, is introduced into the wall of the myocardium MYO as follows.
  • the stent delivery catheter 22 is advanced over a puncture mechanism 24 and into the wall of the myocardium MYO as described above.
  • its retaining sheath 26 is withdrawn, allowing the stent 20 to expand and open a conduit from the ventricle LV to the coronary artery CA.
  • This stent 20 also includes attachment mechanisms not limited to hooks, barbs, flanges, large collars, suture holes and/or other means to ensure a seal is created between the artery CA and the wall of the myocardium MYO, and to prevent the threat of stent 20 migration.
  • attachment mechanisms not limited to hooks, barbs, flanges, large collars, suture holes and/or other means to ensure a seal is created between the artery CA and the wall of the myocardium MYO, and to prevent the threat of stent 20 migration.
  • FIG. 5 The self-expanding stent 20 mounted on the distal end of the stent introducer catheter 22 is illustrated in FIG. 5 .
  • FIG. 6 illustrates the stent introducer 22 following the path created by a puncture wire 24 used to form the passage between the coronary artery CA and the left ventricle LV.
  • FIG. 7 illustrates a non-expanded stent 20 located in position on the stent introducer catheter 22 with the introducer catheter 22 in position in the heart wall MYO.
  • FIG. 8 illustrates the self-expanding stent 20 in position, with the introducing catheter 22 removed. Flared edges 28 on the stent 20 maintain its proper position in the heart wall MYO and provide a seal between the coronary vessel CA and outer surface of the heart MYO.
  • additional anchoring methods may be desired to maintain the stent's proper position and/or create a leak-free seal in the coronary artery.
  • Suitable attachment mechanisms include a set of barbs located on the stent body or flares and a collar on the coronary side to help seal and prevent blood from exiting the gap between the vessel and outer heart wall.
  • the stent can also be anchored in place by applying sutures.
  • the stent can include holes at either end to facilitate the placement of these anchoring sutures.
  • a suture gun can be used to apply multiple sutures at the same time.
  • the stents can be lined, if desired, with materials such as polymers, for example polytetrafluoroethylene (PTFE), silicone or GORTEX, to provide for the ease of blood flow therethrough.
  • a third embodiment of the stent design incorporates attachment flanges or “legs” 30 that expand after introduction into the myocardium to hold the stent 34 in place.
  • the puncture instrument 32 and stent 34 are mated together and are advanced into the myocardial wall as a single unit.
  • the puncture instrument's distal end 36 is shaped in a “nose-cone” configuration, which is responsible for containing the legs 30 of the stent 34 while it is being introduced into the wall of the myocardium.
  • the nose cone 36 is pushed forward, releasing the attachment legs 30 of the stent 34 .
  • the internal diameter (ID) of the stent 34 is large enough to allow the nose cone 36 to pass back through. The stent 34 is then released from the catheter 38 and the catheter 38 is removed.
  • FIG. 9 illustrates the stent 34 mounted on the introducer catheter 38 .
  • the expanding legs 30 of the stent 34 are held in place by the nose cone 36 on the distal end of the catheter 38 that acts as a dilator.
  • the catheter assembly 38 is advanced over a puncture wire if desired, into proper position in the myocardium, and the nose cone 36 is pushed forward allowing the legs 30 to expand as shown in FIG. 10 .
  • the nosecone/puncture assembly 32 , 36 is then withdrawn through the lumen of the stent 34 .
  • the stent 34 can be pushed off the introducer catheter 38 and remains in the myocardium in the position shown in FIG. 11 .
  • FIG. 9 illustrates the stent 34 mounted on the introducer catheter 38 .
  • the expanding legs 30 of the stent 34 are held in place by the nose cone 36 on the distal end of the catheter 38 that acts as a dilator.
  • the catheter assembly 38 is advanced over a puncture wire if
  • FIG. 11 also illustrates a sealing collar 44 that may be used in the interface between the coronary artery and the outer wall of the heart to prevent hemorrhaging around the stent 34 and to hold the stent 34 in place. Sutures can be used to ensure that the stent is maintained in its proper position and prevent migration.
  • FIG. 12 illustrates a further embodiment of the present invention, a “bulkhead” stent 50 .
  • This stent 50 consists of a plurality of rings, which are placed in the myocardium MYO.
  • the rings 50 form a passage through which blood flows from a chamber in the heart, such as the left ventricle LV, directly into the coronary artery CA.
  • the stent 50 is preferably formed of biocompatible material such as a metal or polymer.
  • a gun or other suitable device can be used to implant the stent 50 in the myocardium MYO.
  • the separate units or rings of the stent 50 can be connected via a wire, suture thread, or similar means.
  • the wire is threaded through the holes 51 located in each ring. Connecting the rings of the stent 50 in this manner serves to make the stent 50 more stable and to prevent the migration of the individual units.
  • a valve (not shown) can be incorporated into the stent 50 to help prevent the backflow of blood into the left ventricle LV. Additional details regarding valve designs are disclosed in the above referenced copending applications entitled LEFT VENTRICULAR CONDUIT WITH BLOOD VESSEL GRAFT, U.S. patent application Ser. No. 09/369,061, now U.S. Pat. No.
  • the stent or conduit of the present invention can be formed of biodegradable or bioabsorbable materials and/or used to deliver drugs directly into the myocardium and the coronary circulation.
  • a stent 52 is illustrated in FIG. 13 .
  • the biodegradable stent 52 can extend only partially through the myocardium MYO as illustrated in FIG. 13 , but can also extend entirely through from the left ventricle LV to the coronary artery CA. Once positioned in the myocardium MYO, the stent 52 degrades, dissolves or is absorbed over time to release drugs, genes, angiogenesis or growth factors, or other pharmaceutical compounds directly into the heart muscle MYO and the coronary artery CA, as shown by the arrows in FIG. 13 .
  • Bioabsorbable materials include, but are not limited to, polymers of the linear aliphatic polyester and glycolide families, such as polylactide and polyglycolide. Further details are described in the above-referenced application entitled LEFT VENTRICULAR CONDUITS TO CORONARY ARTERIES AND METHODS FOR CORONARY BYPASS, U.S. patent application Ser. No. 09/369,039, now abandoned, filed on Aug. 4, 1999.
  • FIGS. 14-26 there is illustrated in greater detail one preferred method and apparatus for providing a bulkhead stent 50 , as shown in FIG. 12 , into the myocardium MYO.
  • a stent delivery catheter 60 is advanced over a puncture wire 62 and into the wall of the myocardium MYO as described above.
  • the stent delivery catheter 60 follows the path created by the puncture wire 62 used to form the passage between the coronary artery CA and the left ventricle LV.
  • FIG. 15 illustrates a bulkhead stent 50 still located in position inside the stent delivery catheter 60 with the catheter 60 in position in the heart wall MYO.
  • FIGS. 16-19 show one embodiment for deploying the bulkhead stent 50 into the myocardium MYO.
  • the rings comprising the bulkhead stent 50 are deployed into the myocardium MYO.
  • FIGS. 20 and 21 are enlarged views of FIGS. 18 and 19 , showing the rings of the bulkhead stent 50 positioned within the myocardium MYO to form the passageway therethrough.
  • FIGS. 22-25 illustrate more particularly the structure and deployment of the rings comprising the bulkhead stent 50 .
  • the bulkhead stent comprises a plurality of rings 64 that are initially loaded into the delivery catheter 60 . While inside the lumen of the catheter 60 , each ring 64 has a loaded configuration 64 A, shown in FIGS. 22 and 25 . After ejectment from the catheter 60 , the ring 64 assumes an inserted configuration 64 B, shown in FIGS. 23 and 25 .
  • the inserted configuration of ring 64 B includes a plurality of flanges 66 around the circumference of each ring 64 , thereby providing a securement mechanism to anchor each ring 64 to the myocardium MYO.
  • Each ring 64 transforms from its loaded configuration 64 A to its inserted configuration 64 B by virtue of being released from the catheter 60 .
  • the catheter 60 acts as a restraint on each ring 64 to keep it in its loaded configuration 64 A.
  • the flanges 66 provided along the circumference of each ring 64 are allowed to extend outward to provide the securement mechanism.
  • FIG. 26 illustrates an inserter device or handle 68 that may be used in deploying the bulkhead stent 50 into the myocardium.
  • the inserter handle 68 preferably comprises a gun 70 with a trigger 72 , and a wire 74 extending from a nozzle 76 .
  • the rings 64 (not shown) of the bulkhead stent 50 are preferably loaded onto the wire 74 , and may be deployed into the myocardium preferably one at a time by pressing the trigger 72 .
  • FIGS. 27-30 illustrate another embodiment of the present invention.
  • a self-expanding spring or screw stent 140 is delivered into the myocardium MYO.
  • a channel 142 through the wall of the myocardium MYO is first created, as described above, using a device 144 delivered through the aorta AO and coronary artery CA.
  • the channel 142 travels from the coronary artery CA through the myocardium MYO and into the left ventricle LV as shown in FIG. 27B .
  • the distal end of the stent delivery catheter 146 bearing the stent 140 is then positioned within the channel 142 , as shown in FIG. 28 .
  • the position of the distal end of the delivery catheter 146 is checked radiographically, to ensure proper positioning.
  • the self-expanding spring stent 140 is delivered into the channel 142 wall of the myocardium MYO.
  • the stent 140 is cut such that it does not extend past the myocardium MYO and into either the left ventricle LV or the coronary artery CA.
  • the proper positioning and length of the stent 140 is preferably checked radiographically and any necessary adjustments made before the delivery catheter 146 is removed, as shown in FIG. 30 .
  • FIG. 31 illustrates another embodiment of the stent 200 having retention members 202 .
  • the hollow stent body 204 is held in place in the heart wall by one or more retention members 202 which are deployed after the stent 200 is properly positioned, as described above.
  • FIG. 31 shows the retention members 202 in their deployed position.
  • a flange 206 acts to seal the opening in the coronary artery, while the retention members 202 reside in the myocardium, helping to anchor the stent 200 in place.
  • stents described above, and particularly the bulkhead stent are useful in other applications in addition to stenting the myocardium.
  • these stents may also serve as other types of coronary stents, arterial or venous stents, as well as billiary and esophageal stents.
  • the present vascular shunt provides significant improvements in the present treatment of blockages in the coronary artery.

Abstract

A conduit is provided to provide a bypass around a blockage in the coronary artery. The conduit is adapted to be positioned in the myocardium or heart wall to provide a passage for blood to flow between a chamber of the heart such as the left ventricle and the coronary artery, distal to the blockage. The stent is self-expanding or uses a balloon to expand the stent in the heart wall. Various attachment means are provided to anchor the stent and prevent its migration.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This is a continuation application of U.S. patent application Ser. No. 10/456,488, filed Jun. 9, 2003, now pending, which is a continuation application of U.S. patent application Ser. No. 09/829,449, filed Apr. 10, 2001, now U.S. Pat. No. 6,610,100, which is a continuation application of U.S. patent application Ser. No. 09/369,048, filed Aug. 4, 1999, now U.S. Pat. No. 6,290,728, and claims the benefits of priority of U.S. Provisional Patent Application No. 60/099,767, filed Sep. 10, 1998, and U.S. Provisional Patent Application No. 60/104,397, filed Oct. 15, 1998, the entirety of all of which are incorporated herein by reference.
  • FIELD OF THE INVENTION
  • The present invention relates to an apparatus for bypassing a blocked blood vessel segment, and, more particularly, to a conduit or stent positioned between the coronary artery or other blocked vessel and a chamber of the heart, such as the left ventricle of the heart, to bypass a blocked segment of the coronary artery or other blood vessel.
  • BACKGROUND OF THE INVENTION
  • Coronary artery disease is a major problem in the U.S. and throughout the world. Coronary arteries as well as other blood vessels frequently become clogged with plaque, which at the very least impairs the efficiency of the heart's pumping action, and can lead to heart attack and death. In some cases, these arteries can be unblocked through noninvasive techniques such as balloon angioplasty. In more difficult cases, a bypass of the blocked vessel is necessary.
  • In a bypass operation, one or more venous segments are inserted between the aorta and the coronary artery. The inserted venous segments or transplants act as a bypass of the blocked portion of the coronary artery and thus provide for a free or unobstructed flow of blood to the heart. More than 500,000 bypass procedures are performed in the U.S. every year.
  • Such coronary artery bypass surgery, however, is a very intrusive procedure that is expensive, time-consuming and traumatic to the patient. The operation requires an incision through the patient's sternum (sternotomy), and that the patient be placed on a bypass pump so that the heart can be operated on while not beating. A vein graft is harvested from the patient's leg, another highly invasive procedure, and a delicate surgical procedure is required to piece the bypass graft to the coronary artery (anastomosis). Hospital stays subsequent to the surgery and convalescence are prolonged.
  • As mentioned above, another conventional treatment is percutaneous transluminal coronary angioplasty (PTCA) or other types of angioplasty. However, such vascular treatments are not always indicated due to the type or location of the blockage, or due to the risk of emboli.
  • Thus, there is a need for an improved bypass system which is less traumatic to the patient.
  • SUMMARY OF THE INVENTION
  • The preferred embodiments of the present invention address the need in the previous technology by providing a bypass system that avoids the sternotomy and other intrusive procedures normally associated with coronary bypass surgery. These embodiments also free the surgeon from the multiple anastomoses necessary in the current process.
  • The preferred device provides a shunt for diverting blood directly from a chamber in the heart, such as the left ventricle, to the coronary artery, distal to the blockage, therefore bypassing the blocked portion of the vessel. The shunt comprises a stent or conduit adapted to be positioned in the heart wall or myocardium between the left ventricle and the coronary artery that allows for the direct passage of blood therethrough. As used herein, the terms “stent” and “conduit” are interchangeable, and refer to a device that allows for the passage of blood therethrough. The terms “myocardium” and “heart wall” are also used interchangeably. In addition, although the left ventricle is referred to throughout the description, it should be understood that the conduit described herein can be used to provide a passageway for the flow of blood from any heart chamber, not only the left ventricle.
  • The stent device is delivered either externally or internally through the coronary artery to a position distal to the blockage. At that position, the coronary artery, the myocardium and the wall of the left ventricle are pierced to provide a channel completely through from the coronary artery to the left ventricle of the heart. The stent is then positioned in the channel to provide a permanent passage for blood to flow between the left ventricle of the heart and the coronary artery, distal to the blockage. The stent is sized so that one open end is positioned within the coronary artery, while the other open end is positioned in the left ventricle. The hollow lumen of the stent provides a passage for the flow of blood.
  • The stent can be self-expandable or expanded by means of a balloon or similar device, and can be provided with various means to anchor it in position within the myocardium, such as expandable legs, hooks, barbs, collars, suture holes and the like. The stent can be formed from a plurality of rings, which can be connected to provide stability. The stent can include a valve in its interior, and can also be used to deliver drugs or other pharmaceutical compounds directly into the myocardium and the coronary circulation.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is a cross-sectional view of a human heart, aorta and coronary artery.
  • FIG. 1B is a side view of one embodiment of an expandable stent and the balloon catheter used for stent delivery.
  • FIG. 2 is a side view of the stent of FIG. 1B mounted on the distal end of the catheter for delivery into the myocardium, with the coronary artery and myocardium shown cut-away.
  • FIG. 3 is a side view of the distal end of the stent/catheter assembly of FIG. 1B positioned in the myocardium, with the coronary artery and myocardium shown cut-away.
  • FIG. 4 is a cross-sectional side view of the stent of FIG. 1B positioned within the myocardium after removal of the catheter used for delivery.
  • FIG. 5 is a side view of another embodiment of the stent and the catheter used for stent delivery.
  • FIG. 6 is a cross-sectional side view of the catheter and puncture device used to introduce the self-expanding stent of FIG. 5 into the myocardium.
  • FIG. 7 is a cross-sectional side view of the stent/catheter assembly of FIG. 5 positioned in the myocardium.
  • FIG. 8 is a side view of the self-expanding stent of FIG. 5 positioned within the myocardium after removal of the catheter and puncture device, with the coronary artery and myocardium shown cut-away.
  • FIG. 9 is a perspective view of another embodiment of the stent having expandable legs, showing the stent mounted on the distal end of the introducer catheter.
  • FIG. 10 is a perspective view of the stent of FIG. 9, showing the distal end of the introducer catheter pushed forward to allow the legs of the stent to expand.
  • FIG. 11 is a perspective view of the stent of FIG. 9, showing the legs of the stent in an expanded position.
  • FIG. 12 is a side view of another embodiment of the stent positioned within the myocardium, with the coronary artery and myocardium shown cut-away.
  • FIG. 13 is a side view of a biodegradable stent positioned within the myocardium, with the coronary artery and myocardium shown cut-away.
  • FIG. 14 is a side view of a catheter and puncture device used to introduce a bulkhead stent into the myocardium, with the coronary artery and myocardium shown cut-away.
  • FIG. 15 is a side view of the stent/catheter assembly of FIG. 14 positioned in the myocardium, with the coronary artery and myocardium shown cutaway.
  • FIGS. 16-19 are progressive side views of the stent/catheter assembly of FIG. 14, showing the bulkhead stent being deployed into the myocardium.
  • FIGS. 20 and 21 are enlarged views of FIGS. 18 and 19, respectively, showing the bulkhead stent being deployed into the myocardium.
  • FIG. 22 is a perspective view of a ring of a bulkhead stent in a loaded configuration
  • FIG. 23 is a perspective view of a ring of a bulkhead stent in an inserted configuration.
  • FIG. 24 is a perspective view of a bulkhead stent within a delivery catheter, showing the rings of the bulkhead stent being inserted.
  • FIG. 25 is a perspective view of a bulkhead stent, with the rings of the stent in loaded and inserted configurations.
  • FIG. 26 is a perspective view of an inserter device used to insert a bulkhead stent.
  • FIG. 27A is a schematic, cross-sectional view of the human heart, showing a catheter used to form a channel through the myocardium and into the left ventricle inserted into the coronary artery.
  • FIG. 27B is an enlarged view of the distal end of the catheter and the channel through the myocardium in FIG. 27A.
  • FIG. 28 is a schematic, cross-sectional view of a stent delivery catheter positioned inside the channel formed in the myocardium.
  • FIG. 29 is a schematic, partial cross-sectional view of a self-expanding spring stent being positioned in the channel formed in the myocardium.
  • FIG. 30 is a schematic, partial cross-sectional view of the self-expanding stent deployed within the myocardium.
  • FIG. 31 is a perspective view of another embodiment of a stent having retention members which maintain the position of the stent.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • As is well known, the coronary artery branches off the aorta and is positioned along the external surface of the heart wall. The anatomy of the human heart is illustrated in FIG. 1A. Oxygenated blood flows from the heart PH to the aorta AO, on to the rest of the body, some of the blood flowing into the coronary artery CA. In some individuals, plaque builds up within the coronary artery CA, blocking the free flow of blood and causing complications ranging from mild angina to heart attack and death.
  • In order to restore the flow of oxygenated blood through the coronary artery, one embodiment of the present invention provides for the shunting of blood directly from the heart to a site in the coronary artery that is distal to the blockage. A channel is formed through the wall of the coronary artery and the myocardium and into the left ventricle of the heart that lies beneath the coronary artery. A stent or conduit is positioned in the passage to keep it open, and allow for the flow of oxygenated blood directly from the heart into the coronary artery. Again, it should be understood that while the insertion of the conduit in the myocardium between the left ventricle and the coronary artery is described in detail below, this is merely exemplary and use of the conduit between other chambers of the heart and the coronary artery, and between blood vessels is also contemplated.
  • The principles of the present invention are not limited to left ventricular conduits, and include conduits for communicating bodily fluids from any space within a patient to another space within a patient, including any mammal. Furthermore, such fluid communication through the conduits is not limited to any particular direction of flow and can be antegrade or retrograde with respect to the normal flow of fluid. Moreover, the conduits may communicate between a bodily space and a vessel or from one vessel to another vessel (such as an artery to a vein or vice versa). Moreover, the conduits can reside in a single bodily space so as to communicate fluids from one portion of the space to another. For example, the conduits can be used to achieve a bypass within a single vessel, such as communicating blood from a proximal portion of an occluded coronary artery to a more distal portion of that same coronary artery.
  • In addition, the conduits and related methods can preferably traverse various intermediate destinations and are not limited to any particular flow sequence. For example, in one preferred embodiment of the present invention, the conduit communicates from the left ventricle, through the myocardium, into the pericardial space, and then into the coronary artery. However, other preferred embodiments are disclosed, including direct transmyocardial communication from a left ventricle, through the myocardium and into the coronary artery. Thus, as emphasized above, the term “transmyocardial” should not be narrowly construed in connection with the preferred fluid communication conduits, and other non-myocardial and even non-cardiac fluid communication are preferred as well. With respect to the walls of the heart (and more specifically the term “heart wall”), the preferred conduits and related methods are capable of fluid communication through all such walls including, without limitation, the pericardium, epicardium, myocardium, endocardium, septum, etc.
  • The bypass which is achieved with certain preferred embodiments and related methods is not limited to a complete bypass of bodily fluid flow, but can also include a partial bypass which advantageously supplements the normal bodily blood flow. Moreover, the occlusions which are bypassed may be of a partial or complete nature, and therefore the terminology “bypass” or “occlusion” should not be construed to be limited to a complete bypass or a complete occlusion but can include partial bypass and partial occlusion as described.
  • The preferred conduits and related methods disclosed herein can also provide complete passages or partial passages through bodily tissues. In this regard, the conduits can comprise stents, shunts, or the like, and therefore provide a passageway or opening for bodily fluid such as blood. Moreover, the conduits are not necessarily stented or lined with a device but can comprise mere tunnels or openings formed in the tissues of the patient.
  • The conduits of the present invention preferably comprise both integral or one-piece conduits as well as plural sections joined together to form a continuous conduit. The present conduits can be deployed in a variety of methods consistent with sound medical practice including vascular or surgical deliveries, including minimally invasive techniques. For example, various preferred embodiments of delivery rods and associated methods may be used. In one embodiment, the delivery rod is solid and trocar-like. It may be rigid or semi-rigid and capable of penetrating the tissues of the patient and thereby form the conduit, in whole or in part, for purposes of fluid communication. In other preferred embodiments, the delivery rods may be hollow so as to form the conduits themselves (e.g., the conduits are preferably self-implanting or self-inserting) or have a conduit mounted thereon (e.g., the delivery rod is preferably withdrawn leaving the conduit installed). Thus, the preferred conduit device and method for installation is preferably determined by appropriate patient indications in accordance with sound medical practices.
  • In some individuals, aortic insufficiency or peripheral venous insufficiency occurs. Aortic insufficiency is the leakage of blood through the aortic valve, resulting in a backflow of blood into the left ventricle. The heart compensates for the backflow of blood by pumping harder, resulting in hypertrophy (thickening of the heart muscle) and dilation of the left ventricle wall. Left untreated, heart failure can result. In venous insufficiency, the heart valves are unable to prevent the backflow of blood. This too can result in heart failure. Accordingly, one embodiment of the invention provides for the use of a conduit placed within the heart wall to improve the flow of oxygenated blood through the body.
  • A first embodiment of the present invention is illustrated in FIG. 1B. This embodiment is a balloon-expanded stent 10. The stent 10 is introduced as described below, using a high-pressure balloon catheter 12 to deploy the stent 10 once it is properly positioned in the myocardium MYO (FIG. 2). When the stent 10 is positioned inside the myocardial wall MYO, the balloon 14 is inflated to expand the stent 10 and open the conduit from the left ventricle LV into the coronary artery CA. The stent 10 can include attachment mechanisms not limited to hooks, barbs, flanges, large collars, suture holes and/or other means to ensure a seal is created between the coronary artery CA and the wall of the myocardium MYO and to prevent the threat of stent 10 migration. When the attachment of the stent 10 is completed, the remaining catheter assembly 12 is removed, leaving the stent 10 in place. Upon deflating the balloon 14, the stent 10 will remain open. Because of the shape of this stent 10, a dumbbell shaped balloon 14 is preferably used to ensure proper expansion, as described below.
  • FIGS. 1B through 4 illustrate the introduction of the balloon-expanded stent 10 into the myocardial wall MYO. FIG. 1B illustrates the stent 10 mounted over the balloon 14 on the distal end of the stent introducer catheter 12. FIG. 2 illustrates the stent introducer catheter 12 following the path created by a puncture wire 16 extending past the distal end of the introducer catheter 12, and used to access the left ventricle LV through the coronary artery CA and myocardium MYO. Further details regarding conduits and conduit delivery systems are described in copending patent applications entitled DELIVERY METHODS FOR LEFT VENTRICULAR CONDUIT, U.S. patent application Ser. No. 09/368,868, now U.S. Pat. No. 6,261,304, LEFT VENTRICULAR CONDUIT WITH BLOOD VESSEL GRAFT, U.S. patent application Ser. No. 09/369,061, now U.S. Pat. No. 6,254,564, VALVE DESIGNS FOR LEFT VENTRICULAR CONDUIT, U.S. patent application Ser. No. 09/368,393, now U.S. Pat. No. 6,641,610, LEFT VENTRICULAR CONDUITS TO CORONARY ARTERIES AND METHODS FOR CORONARY BYPASS, U.S. patent application Ser. No. 09/369,039, now abandoned, and BLOOD FLOW CONDUIT DELIVERY SYSTEM AND METHOD OF USE, U.S. patent application Ser. No. 09/368,644, now U.S. Pat. No. 6,302,892, all filed on Aug. 4, 1999, and U.S. Pat. Nos. 5,429,144 and 5,662,124, the disclosures of which are all hereby incorporated by reference in their entirety.
  • FIG. 3 illustrates the non-expanded stent 10 positioned inside the myocardial wall MYO prior to inflation of the balloon 14. FIG. 4 illustrates an expanded stent 10 in position, with the introducer catheter 12 removed. Because of the way the attachment mechanisms 18 expand on this stent 10, a dumbbell shaped balloon 14 is preferably used to flare out the ends of the stent 10. These flared edges 18 maintain the stent 10 in its proper position in the heart wall MYO and provide a seal between the coronary artery CA and the outer heart wall MYO.
  • The second embodiment of the stent or conduit incorporates a self-expanding stent 20, illustrated in FIGS. 5-8. The stent 20, having a retaining sheath 26 to hold it in a non-expanded configuration, is introduced into the wall of the myocardium MYO as follows. The stent delivery catheter 22 is advanced over a puncture mechanism 24 and into the wall of the myocardium MYO as described above. When the stent 20 is properly seated in the myocardial wall MYO, its retaining sheath 26 is withdrawn, allowing the stent 20 to expand and open a conduit from the ventricle LV to the coronary artery CA. This stent 20 also includes attachment mechanisms not limited to hooks, barbs, flanges, large collars, suture holes and/or other means to ensure a seal is created between the artery CA and the wall of the myocardium MYO, and to prevent the threat of stent 20 migration. When the positioning is completed, the remaining catheter assembly 22 is removed, leaving the stent 20 in place.
  • The self-expanding stent 20 mounted on the distal end of the stent introducer catheter 22 is illustrated in FIG. 5. FIG. 6 illustrates the stent introducer 22 following the path created by a puncture wire 24 used to form the passage between the coronary artery CA and the left ventricle LV. FIG. 7 illustrates a non-expanded stent 20 located in position on the stent introducer catheter 22 with the introducer catheter 22 in position in the heart wall MYO. FIG. 8 illustrates the self-expanding stent 20 in position, with the introducing catheter 22 removed. Flared edges 28 on the stent 20 maintain its proper position in the heart wall MYO and provide a seal between the coronary vessel CA and outer surface of the heart MYO.
  • For the stent designs described above, additional anchoring methods may be desired to maintain the stent's proper position and/or create a leak-free seal in the coronary artery. Suitable attachment mechanisms include a set of barbs located on the stent body or flares and a collar on the coronary side to help seal and prevent blood from exiting the gap between the vessel and outer heart wall. The stent can also be anchored in place by applying sutures. The stent can include holes at either end to facilitate the placement of these anchoring sutures. A suture gun can be used to apply multiple sutures at the same time. In addition, the stents can be lined, if desired, with materials such as polymers, for example polytetrafluoroethylene (PTFE), silicone or GORTEX, to provide for the ease of blood flow therethrough.
  • A third embodiment of the stent design, illustrated in FIGS. 9-11, incorporates attachment flanges or “legs” 30 that expand after introduction into the myocardium to hold the stent 34 in place. The puncture instrument 32 and stent 34 are mated together and are advanced into the myocardial wall as a single unit. The puncture instrument's distal end 36 is shaped in a “nose-cone” configuration, which is responsible for containing the legs 30 of the stent 34 while it is being introduced into the wall of the myocardium. When the stent 34 is in the proper position in the myocardial wall, the nose cone 36 is pushed forward, releasing the attachment legs 30 of the stent 34. The internal diameter (ID) of the stent 34 is large enough to allow the nose cone 36 to pass back through. The stent 34 is then released from the catheter 38 and the catheter 38 is removed.
  • FIG. 9 illustrates the stent 34 mounted on the introducer catheter 38. The expanding legs 30 of the stent 34 are held in place by the nose cone 36 on the distal end of the catheter 38 that acts as a dilator. The catheter assembly 38 is advanced over a puncture wire if desired, into proper position in the myocardium, and the nose cone 36 is pushed forward allowing the legs 30 to expand as shown in FIG. 10. The nosecone/ puncture assembly 32, 36 is then withdrawn through the lumen of the stent 34. When the nose-cone/ puncture assembly 32, 36 is removed, the stent 34 can be pushed off the introducer catheter 38 and remains in the myocardium in the position shown in FIG. 11. FIG. 11 also illustrates a sealing collar 44 that may be used in the interface between the coronary artery and the outer wall of the heart to prevent hemorrhaging around the stent 34 and to hold the stent 34 in place. Sutures can be used to ensure that the stent is maintained in its proper position and prevent migration.
  • FIG. 12 illustrates a further embodiment of the present invention, a “bulkhead” stent 50. This stent 50 consists of a plurality of rings, which are placed in the myocardium MYO. The rings 50 form a passage through which blood flows from a chamber in the heart, such as the left ventricle LV, directly into the coronary artery CA. The stent 50 is preferably formed of biocompatible material such as a metal or polymer. A gun or other suitable device can be used to implant the stent 50 in the myocardium MYO.
  • If desired, the separate units or rings of the stent 50 can be connected via a wire, suture thread, or similar means. The wire is threaded through the holes 51 located in each ring. Connecting the rings of the stent 50 in this manner serves to make the stent 50 more stable and to prevent the migration of the individual units. If desired, a valve (not shown) can be incorporated into the stent 50 to help prevent the backflow of blood into the left ventricle LV. Additional details regarding valve designs are disclosed in the above referenced copending applications entitled LEFT VENTRICULAR CONDUIT WITH BLOOD VESSEL GRAFT, U.S. patent application Ser. No. 09/369,061, now U.S. Pat. No. 6,254,564, VALVE DESIGNS FOR LEFT VENTRICULAR CONDUIT, U.S. patent application Ser. No. 09/368,393, now U.S. Pat. No. 6,641,610 and LEFT VENTRICULAR CONDUITS TO CORONARY ARTERIES AND METHODS FOR CORONARY BYPASS, U.S. patent application Ser. No. 09/369,039, now abandoned, filed on Aug. 4, 1999, all of which are incorporated by reference in their entirety.
  • If desired, the stent or conduit of the present invention can be formed of biodegradable or bioabsorbable materials and/or used to deliver drugs directly into the myocardium and the coronary circulation. Such a stent 52 is illustrated in FIG. 13. The biodegradable stent 52 can extend only partially through the myocardium MYO as illustrated in FIG. 13, but can also extend entirely through from the left ventricle LV to the coronary artery CA. Once positioned in the myocardium MYO, the stent 52 degrades, dissolves or is absorbed over time to release drugs, genes, angiogenesis or growth factors, or other pharmaceutical compounds directly into the heart muscle MYO and the coronary artery CA, as shown by the arrows in FIG. 13. Bioabsorbable materials include, but are not limited to, polymers of the linear aliphatic polyester and glycolide families, such as polylactide and polyglycolide. Further details are described in the above-referenced application entitled LEFT VENTRICULAR CONDUITS TO CORONARY ARTERIES AND METHODS FOR CORONARY BYPASS, U.S. patent application Ser. No. 09/369,039, now abandoned, filed on Aug. 4, 1999.
  • Turning now to FIGS. 14-26, there is illustrated in greater detail one preferred method and apparatus for providing a bulkhead stent 50, as shown in FIG. 12, into the myocardium MYO. As shown in FIG. 14, a stent delivery catheter 60 is advanced over a puncture wire 62 and into the wall of the myocardium MYO as described above. The stent delivery catheter 60 follows the path created by the puncture wire 62 used to form the passage between the coronary artery CA and the left ventricle LV. FIG. 15 illustrates a bulkhead stent 50 still located in position inside the stent delivery catheter 60 with the catheter 60 in position in the heart wall MYO. FIGS. 16-19 show one embodiment for deploying the bulkhead stent 50 into the myocardium MYO. As the delivery catheter 60 is retracted proximally from the myocardium MYO, the rings comprising the bulkhead stent 50 are deployed into the myocardium MYO. FIGS. 20 and 21 are enlarged views of FIGS. 18 and 19, showing the rings of the bulkhead stent 50 positioned within the myocardium MYO to form the passageway therethrough.
  • FIGS. 22-25 illustrate more particularly the structure and deployment of the rings comprising the bulkhead stent 50. As shown in FIG. 24, the bulkhead stent comprises a plurality of rings 64 that are initially loaded into the delivery catheter 60. While inside the lumen of the catheter 60, each ring 64 has a loaded configuration 64A, shown in FIGS. 22 and 25. After ejectment from the catheter 60, the ring 64 assumes an inserted configuration 64B, shown in FIGS. 23 and 25. Preferably, the inserted configuration of ring 64B includes a plurality of flanges 66 around the circumference of each ring 64, thereby providing a securement mechanism to anchor each ring 64 to the myocardium MYO. Each ring 64 transforms from its loaded configuration 64A to its inserted configuration 64B by virtue of being released from the catheter 60. Specifically, the catheter 60 acts as a restraint on each ring 64 to keep it in its loaded configuration 64A. Then, once the ring 64 is released from the catheter 60, the flanges 66 provided along the circumference of each ring 64 are allowed to extend outward to provide the securement mechanism.
  • FIG. 26 illustrates an inserter device or handle 68 that may be used in deploying the bulkhead stent 50 into the myocardium. The inserter handle 68 preferably comprises a gun 70 with a trigger 72, and a wire 74 extending from a nozzle 76. The rings 64 (not shown) of the bulkhead stent 50 are preferably loaded onto the wire 74, and may be deployed into the myocardium preferably one at a time by pressing the trigger 72.
  • FIGS. 27-30 illustrate another embodiment of the present invention. Here, a self-expanding spring or screw stent 140 is delivered into the myocardium MYO. As illustrated in FIG. 27A, a channel 142 through the wall of the myocardium MYO is first created, as described above, using a device 144 delivered through the aorta AO and coronary artery CA. The channel 142 travels from the coronary artery CA through the myocardium MYO and into the left ventricle LV as shown in FIG. 27B. The distal end of the stent delivery catheter 146 bearing the stent 140 is then positioned within the channel 142, as shown in FIG. 28. Preferably, the position of the distal end of the delivery catheter 146 is checked radiographically, to ensure proper positioning. Next, as illustrated in FIG. 29, the self-expanding spring stent 140 is delivered into the channel 142 wall of the myocardium MYO. The stent 140 is cut such that it does not extend past the myocardium MYO and into either the left ventricle LV or the coronary artery CA. Again, the proper positioning and length of the stent 140 is preferably checked radiographically and any necessary adjustments made before the delivery catheter 146 is removed, as shown in FIG. 30.
  • FIG. 31 illustrates another embodiment of the stent 200 having retention members 202. The hollow stent body 204 is held in place in the heart wall by one or more retention members 202 which are deployed after the stent 200 is properly positioned, as described above. FIG. 31 shows the retention members 202 in their deployed position. A flange 206 acts to seal the opening in the coronary artery, while the retention members 202 reside in the myocardium, helping to anchor the stent 200 in place.
  • It should be appreciated that the stents described above, and particularly the bulkhead stent, are useful in other applications in addition to stenting the myocardium. For example, these stents may also serve as other types of coronary stents, arterial or venous stents, as well as billiary and esophageal stents.
  • The present vascular shunt provides significant improvements in the present treatment of blockages in the coronary artery. Although the invention has been described in its preferred embodiments in connection with the particular figures, it is not intended that this description should be limited in any way.

Claims (16)

1-13. (canceled)
14. A tissue implant device for implantation into ischemic tissue comprising:
an implant having a first configuration with a first profile and a second configuration having a second profile that is greater than the first profile whereby surrounding tissue into which the implant is placed in stress and is irritated sufficiently to cause an injury response including thrombosis formation that initiates angiogenesis;
the implant comprising a plurality of expandable members each having a free end and an end joined to the implant, each member configured to diverge away from a substantially common central longitudinal axis of the implant during self-expansion from the first configuration to the second configuration.
15. An implant as defined in claim 14 further comprising a flare that is resiliently expandable from the first configuration to the second configuration.
16. An implant device as defined in claim 14 wherein the implant defines a hollow interior.
17. An implant device as defined in claim 14 wherein the implant is flexible after assuming the second configuration.
18. An implant device as defined in claim 14 wherein the implant defines a trunk portion aligned along the longitudinal axis of the implant and defining expandable members that are legs extending from the trunk portion and that diverge away from the longitudinal axis upon expansion.
19. An implant device as defined in claim 14 wherein a first portion of the body aligned along the longitudinal axis of the implant remains static during and after delivery and a second portion of the body is defined by expandable members that move to a different position relative to the first portion after implantation to comprise a second configuration of the device.
20. An implant device as defined in claim 19 wherein the implant comprises an elastic material and the motivational energy to cause the implant to move from the first to the second configuration is the inherent resiliency of the material.
21. A tissue implant device for implantation into ischemic tissue comprising:
an implant having a first configuration with a first profile and a second configuration having a second profile that is greater than the first profile;
the implant comprising a plurality of expandable members each having a free end and an end joined to the implant, each member configured to diverge away from a substantially common central longitudinal axis of the implant during self-expansion from the first configuration to the second configuration.
22. An implant device as defined in claim 21 further comprising a flare, a leg, a flange, a hook, a barb, or a collar that is resiliently expandable from the first configuration to the second configuration.
23. An implant device as defined in claim 21 wherein the implant defines a hollow interior.
24. An implant device as defined in claim 21 wherein the implant is flexible after assuming the second configuration.
25. An implant device as defined in claim 21 wherein the implant defines a trunk portion aligned along the longitudinal axis of the implant and defining expandable members that are legs extending from the trunk portion and that diverge away from the longitudinal axis upon expansion.
26. An implant device as defined in claim 21 wherein a first portion of the body aligned along the longitudinal axis of the implant remains static during and after delivery and a second portion of the body is defined by expandable members that move to a different position relative to the first portion after implantation to comprise a second configuration of the device.
27. An implant device as defined in claim 26 wherein the implant comprises an elastic material and the motivational energy to cause the implant to move from the first to the second configuration is the inherent resiliency of the material.
28. A method for placing a conduit in the wall of a patient's heart to establish a blood flow path between a coronary vessel and a heart chamber, the method comprising steps of:
(a) positioning a guide member that extends through the coronary vessel and the heart wall into a heart chamber;
(b) using the guide member to deliver a conduit into the heart chamber; and
(c) positioning the conduit in the heart wall to establish a blood flow path between the heart chamber and the interior of the vessel;
wherein the conduit is covered by a sheath, and further comprising covering at least a portion of the conduit while placing the conduit in the heart wall and then removing the sheath.
US11/246,219 1998-09-10 2005-10-11 Designs for left ventricular conduit Abandoned US20060041218A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/246,219 US20060041218A1 (en) 1998-09-10 2005-10-11 Designs for left ventricular conduit

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US9976798P 1998-09-10 1998-09-10
US10439798P 1998-10-15 1998-10-15
US09/369,048 US6290728B1 (en) 1998-09-10 1999-08-04 Designs for left ventricular conduit
US09/829,449 US6610100B2 (en) 1998-09-10 2001-04-10 Designs for left ventricular conduit
US10/456,488 US7101402B2 (en) 1998-09-10 2003-06-09 Designs for left ventricular conduit
US11/246,219 US20060041218A1 (en) 1998-09-10 2005-10-11 Designs for left ventricular conduit

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/456,488 Continuation US7101402B2 (en) 1998-09-10 2003-06-09 Designs for left ventricular conduit

Publications (1)

Publication Number Publication Date
US20060041218A1 true US20060041218A1 (en) 2006-02-23

Family

ID=27378897

Family Applications (6)

Application Number Title Priority Date Filing Date
US09/369,048 Expired - Fee Related US6290728B1 (en) 1998-09-10 1999-08-04 Designs for left ventricular conduit
US09/829,449 Expired - Fee Related US6610100B2 (en) 1998-09-10 2001-04-10 Designs for left ventricular conduit
US10/339,385 Expired - Fee Related US7347867B2 (en) 1998-09-10 2003-01-10 Designs for left ventricular conduit
US10/456,488 Expired - Fee Related US7101402B2 (en) 1998-09-10 2003-06-09 Designs for left ventricular conduit
US10/873,642 Expired - Fee Related US6953481B2 (en) 1998-09-10 2004-06-23 Designs for left ventricular conduit
US11/246,219 Abandoned US20060041218A1 (en) 1998-09-10 2005-10-11 Designs for left ventricular conduit

Family Applications Before (5)

Application Number Title Priority Date Filing Date
US09/369,048 Expired - Fee Related US6290728B1 (en) 1998-09-10 1999-08-04 Designs for left ventricular conduit
US09/829,449 Expired - Fee Related US6610100B2 (en) 1998-09-10 2001-04-10 Designs for left ventricular conduit
US10/339,385 Expired - Fee Related US7347867B2 (en) 1998-09-10 2003-01-10 Designs for left ventricular conduit
US10/456,488 Expired - Fee Related US7101402B2 (en) 1998-09-10 2003-06-09 Designs for left ventricular conduit
US10/873,642 Expired - Fee Related US6953481B2 (en) 1998-09-10 2004-06-23 Designs for left ventricular conduit

Country Status (1)

Country Link
US (6) US6290728B1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030212413A1 (en) * 1999-08-04 2003-11-13 Percardia, Inc. Blood flow conduit delivery system and method of use
US20030220661A1 (en) * 2002-05-21 2003-11-27 Heartstent Corporation Transmyocardial implant delivery system
US20040186507A1 (en) * 1998-09-10 2004-09-23 Percardia, Inc. Stent delivery system and method of use
EP2111243A2 (en) * 2006-11-09 2009-10-28 Contract Medical International Gmbh Cardiovascular procedures
US7704222B2 (en) 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent

Families Citing this family (207)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662124A (en) * 1996-06-19 1997-09-02 Wilk Patent Development Corp. Coronary artery by-pass method
US5755682A (en) * 1996-08-13 1998-05-26 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
AU744343B2 (en) * 1997-04-11 2002-02-21 Transvascular, Inc. Methods and apparatus for transmyocardial direct coronary revascularization
US6651670B2 (en) * 1998-02-13 2003-11-25 Ventrica, Inc. Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
US6290728B1 (en) 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US6261304B1 (en) 1998-09-10 2001-07-17 Percardia, Inc. Delivery methods for left ventricular conduit
EP1112043B1 (en) * 1998-09-10 2006-04-05 Percardia, Inc. Tmr shunt
WO2000015147A1 (en) 1998-09-10 2000-03-23 Percardia, Inc. Transmycardial shunt and its attachment mechanism, for left ventricular revascularization
BR0010055A (en) 1999-04-26 2002-04-09 Gmp Vision Solutions Inc Bypass device and use thereof
US6409697B2 (en) * 1999-05-04 2002-06-25 Heartstent Corporation Transmyocardial implant with forward flow bias
US6638237B1 (en) 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
US6253768B1 (en) 1999-08-04 2001-07-03 Percardia, Inc. Vascular graft bypass
US6605053B1 (en) 1999-09-10 2003-08-12 Percardia, Inc. Conduit designs and related methods for optimal flow control
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
JP3782297B2 (en) * 2000-03-28 2006-06-07 株式会社東芝 Solid-state imaging device and manufacturing method thereof
US7660621B2 (en) 2000-04-07 2010-02-09 Medtronic, Inc. Medical device introducer
US6638239B1 (en) 2000-04-14 2003-10-28 Glaukos Corporation Apparatus and method for treating glaucoma
US7867186B2 (en) 2002-04-08 2011-01-11 Glaukos Corporation Devices and methods for treatment of ocular disorders
US7135009B2 (en) 2001-04-07 2006-11-14 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
US6854467B2 (en) * 2000-05-04 2005-02-15 Percardia, Inc. Methods and devices for delivering a ventricular stent
US6902569B2 (en) 2000-08-17 2005-06-07 Image-Guided Neurologics, Inc. Trajectory guide with instrument immobilizer
US6843802B1 (en) * 2000-11-16 2005-01-18 Cordis Corporation Delivery apparatus for a self expanding retractable stent
EP1341476A2 (en) * 2000-12-01 2003-09-10 Nephros Therapeutics, Inc. Intrasvascular drug delivery device and use therefor
US20020099392A1 (en) * 2001-01-24 2002-07-25 Mowry David H. Autoanastomosis device and connection technique
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US20040138734A1 (en) * 2001-04-11 2004-07-15 Trivascular, Inc. Delivery system and method for bifurcated graft
US6620122B2 (en) * 2001-04-26 2003-09-16 Scimed Life Systems, Inc. Gastric pseudocyst drainage and stent delivery system for use therein
US7993365B2 (en) * 2001-06-08 2011-08-09 Morris Innovative, Inc. Method and apparatus for sealing access
US6592608B2 (en) * 2001-12-07 2003-07-15 Biopsy Sciences, Llc Bioabsorbable sealant
US20030036698A1 (en) * 2001-08-16 2003-02-20 Robert Kohler Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts
US7331984B2 (en) 2001-08-28 2008-02-19 Glaukos Corporation Glaucoma stent for treating glaucoma and methods of use
US7708712B2 (en) 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US20100016943A1 (en) 2001-12-20 2010-01-21 Trivascular2, Inc. Method of delivering advanced endovascular graft
US7008397B2 (en) * 2002-02-13 2006-03-07 Percardia, Inc. Cardiac implant and methods
US9301875B2 (en) 2002-04-08 2016-04-05 Glaukos Corporation Ocular disorder treatment implants with multiple opening
US20030216801A1 (en) * 2002-05-17 2003-11-20 Heartstent Corporation Transmyocardial implant with natural vessel graft and method
US20030229392A1 (en) * 2002-06-03 2003-12-11 Wong Samuel J. Drug eluted vascular graft
US7326219B2 (en) * 2002-09-09 2008-02-05 Wilk Patent Development Device for placing transmyocardial implant
US7704260B2 (en) 2002-09-17 2010-04-27 Medtronic, Inc. Low profile instrument immobilizer
FR2846520B1 (en) * 2002-11-06 2006-09-29 Roquette Freres USE OF MALTODEXTRINS BRANCHED AS BLEACHES OF GRANULATION
US7384389B2 (en) * 2002-12-19 2008-06-10 Fernando Anzellini Paradoxical flow valve of the heart
US7636596B2 (en) 2002-12-20 2009-12-22 Medtronic, Inc. Organ access device and method
US6928669B2 (en) * 2003-01-10 2005-08-16 Tyler Pipe Company Closet carrier system and method of assembly
US20040147868A1 (en) * 2003-01-27 2004-07-29 Earl Bardsley Myocardial implant with collar
US7896889B2 (en) 2003-02-20 2011-03-01 Medtronic, Inc. Trajectory guide with angled or patterned lumens or height adjustment
WO2004082525A2 (en) 2003-03-14 2004-09-30 Sinexus, Inc. Sinus delivery of sustained release therapeutics
US20040254627A1 (en) * 2003-04-04 2004-12-16 Thompson Paul J. Stent with end adapted for flaring
US7481834B2 (en) * 2003-04-14 2009-01-27 Tryton Medical, Inc. Stent for placement at luminal os
US7731747B2 (en) 2003-04-14 2010-06-08 Tryton Medical, Inc. Vascular bifurcation prosthesis with multiple thin fronds
US7717953B2 (en) 2004-10-13 2010-05-18 Tryton Medical, Inc. Delivery system for placement of prosthesis at luminal OS
US7758630B2 (en) 2003-04-14 2010-07-20 Tryton Medical, Inc. Helical ostium support for treating vascular bifurcations
US8109987B2 (en) 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7972372B2 (en) 2003-04-14 2011-07-05 Tryton Medical, Inc. Kit for treating vascular bifurcations
US8083791B2 (en) 2003-04-14 2011-12-27 Tryton Medical, Inc. Method of treating a lumenal bifurcation
EP1633320A2 (en) 2003-05-02 2006-03-15 SurModics, Inc. Implantable controlled release bioactive agent delivery device
US8246974B2 (en) 2003-05-02 2012-08-21 Surmodics, Inc. Medical devices and methods for producing the same
US8512403B2 (en) * 2003-05-20 2013-08-20 The Cleveland Clinic Foundation Annuloplasty ring with wing members for repair of a cardiac valve
US20060217797A1 (en) * 2003-05-23 2006-09-28 Wong Samuel J Asymmetric drug eluting hemodialysis graft
US8308682B2 (en) 2003-07-18 2012-11-13 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
IES20030539A2 (en) * 2003-07-22 2005-05-18 Medtronic Vascular Connaught Stents and stent delivery system
DE10334868B4 (en) 2003-07-29 2013-10-17 Pfm Medical Ag Implantable device as a replacement organ valve, its manufacturing process and basic body and membrane element for it
US9078780B2 (en) * 2003-11-08 2015-07-14 Cook Medical Technologies Llc Balloon flareable branch vessel prosthesis and method
US20050182424A1 (en) 2004-02-13 2005-08-18 Schulte Gregory T. Methods and apparatus for securing a therapy delivery device within a burr hole
AU2005232545B2 (en) 2004-03-31 2010-08-12 Cook Medical Technologies Llc Stent deployment device
US8048140B2 (en) 2004-03-31 2011-11-01 Cook Medical Technologies Llc Fenestrated intraluminal stent system
US8425539B2 (en) 2004-04-12 2013-04-23 Xlumena, Inc. Luminal structure anchoring devices and methods
WO2005104992A1 (en) * 2004-04-26 2005-11-10 Bioduct Llc Stent for avascular meniscal repair and regeneration
US20050278013A1 (en) * 2004-05-26 2005-12-15 Matthew Rust Method for endovascular bypass stent graft delivery
US20050288618A1 (en) * 2004-06-24 2005-12-29 Scimed Life Systems, Inc. Myocardial treatment apparatus and method
US8409167B2 (en) 2004-07-19 2013-04-02 Broncus Medical Inc Devices for delivering substances through an extra-anatomic opening created in an airway
US9138228B2 (en) 2004-08-11 2015-09-22 Emory University Vascular conduit device and system for implanting
US20060034891A1 (en) * 2004-08-12 2006-02-16 Laurie Lawin Biodegradable controlled release bioactive agent delivery device
US8202248B2 (en) 2004-08-18 2012-06-19 Sequana Medical Ag Dialysis implant and methods of use
US11207457B2 (en) * 2004-08-27 2021-12-28 Edwards Lifesciences Corporation Device and method for establishing an artificial arterio-venous fistula
US7744606B2 (en) * 2004-12-04 2010-06-29 Medtronic, Inc. Multi-lumen instrument guide
US7497863B2 (en) 2004-12-04 2009-03-03 Medtronic, Inc. Instrument guiding stage apparatus and method for using same
JP5111112B2 (en) 2004-12-08 2012-12-26 エックスルミナ, インコーポレイテッド Device for performing needle-guided therapy
RU2007140909A (en) 2005-04-04 2009-05-20 Синексус, Инк. (Us) DEVICE AND METHODS FOR TREATING DISEASES OF THE NANOLAIN SINUS
US20060247769A1 (en) * 2005-04-28 2006-11-02 Sdgi Holdings, Inc. Polycrystalline diamond compact surfaces on facet arthroplasty devices
US8777967B2 (en) 2005-06-09 2014-07-15 Xlumena, Inc. Methods and devices for anchoring to tissue
US8784437B2 (en) 2005-06-09 2014-07-22 Xlumena, Inc. Methods and devices for endosonography-guided fundoplexy
EP1898811B1 (en) * 2005-06-30 2019-03-06 Rox Medical, Inc. Devices and systems for creation of a peripherally located fistula
US20070066982A1 (en) * 2005-09-19 2007-03-22 Regner Justin L Fistulary catheter
EP1954224B1 (en) * 2005-11-14 2013-05-29 Covidien LP Stent delivery system for ostial locations in a conduit
EP1989144A4 (en) 2006-02-02 2014-01-29 Innovative Bio Therapies An extracorporeal cell-based therapeutic device and delivery system
US20080097620A1 (en) 2006-05-26 2008-04-24 Nanyang Technological University Implantable article, method of forming same and method for reducing thrombogenicity
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
WO2008008794A2 (en) 2006-07-10 2008-01-17 Mc Neil-Ppc, Inc. Resilient device
US7717892B2 (en) 2006-07-10 2010-05-18 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US20080033487A1 (en) * 2006-08-07 2008-02-07 Bioduct, Llc Medical device for repair of tissue and method for implantation and fixation
EP2051646A4 (en) * 2006-08-07 2014-06-11 Howmedica Osteonics Corp Insertion system for implanting a medical device and surgical methods
WO2008036543A2 (en) * 2006-09-18 2008-03-27 C.R. Bard, Inc. Single layer eptfe and discrete bio-resorbable rings
US10413284B2 (en) 2006-11-07 2019-09-17 Corvia Medical, Inc. Atrial pressure regulation with control, sensing, monitoring and therapy delivery
US9232997B2 (en) 2006-11-07 2016-01-12 Corvia Medical, Inc. Devices and methods for retrievable intra-atrial implants
US20110257723A1 (en) 2006-11-07 2011-10-20 Dc Devices, Inc. Devices and methods for coronary sinus pressure relief
US20080109069A1 (en) * 2006-11-07 2008-05-08 Coleman James E Blood perfusion graft
CA2664557C (en) * 2006-11-07 2015-05-26 David Stephen Celermajer Devices and methods for the treatment of heart failure
JP5748407B2 (en) 2006-11-10 2015-07-15 グローコス コーポレーション Uveal sclera shunt
US7846123B2 (en) * 2007-04-24 2010-12-07 Emory University Conduit device and system for implanting a conduit device in a tissue wall
US7850706B2 (en) * 2007-08-08 2010-12-14 Board Of Trustees Of The University Of Arkansas Pancreatic-enteric fistulary catheterization system
US8858576B2 (en) * 2007-09-10 2014-10-14 Olympus Medical Systems Corp. Tissue fastening tool, stent, applicator for placing the same, and tissue fastening method through natural orifice
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US20090082847A1 (en) * 2007-09-26 2009-03-26 Boston Scientific Corporation System and method of securing stent barbs
EP2194921B1 (en) 2007-10-04 2018-08-29 TriVascular, Inc. Modular vascular graft for low profile percutaneous delivery
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8328861B2 (en) * 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US20090143760A1 (en) * 2007-11-30 2009-06-04 Jacques Van Dam Methods, Devices, Kits and Systems for Defunctionalizing the Gallbladder
US8128677B2 (en) 2007-12-12 2012-03-06 Intact Vascular LLC Device and method for tacking plaque to a blood vessel wall
US10022250B2 (en) 2007-12-12 2018-07-17 Intact Vascular, Inc. Deployment device for placement of multiple intraluminal surgical staples
US9375327B2 (en) 2007-12-12 2016-06-28 Intact Vascular, Inc. Endovascular implant
US9603730B2 (en) 2007-12-12 2017-03-28 Intact Vascular, Inc. Endoluminal device and method
US20110230954A1 (en) * 2009-06-11 2011-09-22 Peter Schneider Stent device having focal elevating elements for minimal surface area contact with lumen walls
US7896911B2 (en) * 2007-12-12 2011-03-01 Innovasc Llc Device and method for tacking plaque to blood vessel wall
US10166127B2 (en) 2007-12-12 2019-01-01 Intact Vascular, Inc. Endoluminal device and method
CA2709901C (en) 2007-12-18 2022-05-10 Intersect Ent, Inc. Self-expanding devices and methods therefor
US9480826B2 (en) * 2008-03-21 2016-11-01 Cagent Vascular, Llc Intravascular device
US11219750B2 (en) 2008-03-21 2022-01-11 Cagent Vascular, Inc. System and method for plaque serration
EP2254641B1 (en) 2008-03-21 2016-09-21 Cagent Vascular, LLC Device for pre-angioplasty serration and dilatation
US20090281379A1 (en) 2008-05-12 2009-11-12 Xlumena, Inc. System and method for transluminal access
US8454632B2 (en) 2008-05-12 2013-06-04 Xlumena, Inc. Tissue anchor for securing tissue layers
WO2009155236A1 (en) 2008-06-16 2009-12-23 Morris Innovative Research, Inc. Method and apparatus for sealing access
US20090312645A1 (en) * 2008-06-16 2009-12-17 Boston Scientific Scimed, Inc. Methods and Devices for Accessing Anatomic Structures
EP2291515A2 (en) 2008-06-18 2011-03-09 Innovative Biotherapies, Inc. Methods for propagation of renal precursor cells
US8206635B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US8206636B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US20100022940A1 (en) * 2008-07-25 2010-01-28 Medtronic Vascular, Inc. Percutaneously Introduceable Shunt Devices and Methods
CA2732355A1 (en) 2008-08-01 2010-02-04 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
WO2010123668A1 (en) 2009-04-20 2010-10-28 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9364259B2 (en) 2009-04-21 2016-06-14 Xlumena, Inc. System and method for delivering expanding trocar through a sheath
US20120130417A1 (en) * 2010-10-25 2012-05-24 Keke Lepulu Apparatus and method for penetrating and enlarging adjacent tissue layers
US20210161637A1 (en) 2009-05-04 2021-06-03 V-Wave Ltd. Shunt for redistributing atrial blood volume
EP2429624B1 (en) 2009-05-15 2014-04-02 Intersect ENT, Inc. A combination of an expandable device and a delivery device.
US9901347B2 (en) * 2009-05-29 2018-02-27 Terus Medical, Inc. Biliary shunts, delivery systems, and methods of using the same
WO2010138277A1 (en) 2009-05-29 2010-12-02 Xlumena, Inc. Apparatus and method for deploying stent across adjacent tissue layers
US8366763B2 (en) 2009-07-02 2013-02-05 Tryton Medical, Inc. Ostium support for treating vascular bifurcations
US9757107B2 (en) 2009-09-04 2017-09-12 Corvia Medical, Inc. Methods and devices for intra-atrial shunts having adjustable sizes
EP2528646A4 (en) 2010-01-29 2017-06-28 DC Devices, Inc. Devices and systems for treating heart failure
WO2012071542A2 (en) 2010-11-24 2012-05-31 Tryton Medical, Inc. Support for treating vascular bifurcations
CA2824936A1 (en) 2011-01-28 2012-08-02 Apica Cardiovascular Limited Systems for sealing a tissue wall puncture
WO2012106422A2 (en) 2011-02-01 2012-08-09 Georgia Tech Research Corporation Systems for implanting and using a conduit within a tissue wall
CN103635226B (en) 2011-02-10 2017-06-30 可维亚媒体公司 Device for setting up and keeping intra-atrial pressure power release aperture
US9149613B2 (en) 2011-02-16 2015-10-06 Sequana Medical Ag Apparatus and methods for treating intracorporeal fluid accumulation
CN103501735B (en) 2011-03-08 2016-04-06 W.L.戈尔及同仁股份有限公司 For ostomy medical treatment device
US9345532B2 (en) 2011-05-13 2016-05-24 Broncus Medical Inc. Methods and devices for ablation of tissue
US8709034B2 (en) 2011-05-13 2014-04-29 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US10390977B2 (en) 2011-06-03 2019-08-27 Intact Vascular, Inc. Endovascular implant
EP2535025A1 (en) 2011-06-17 2012-12-19 Cook Medical Technologies LLC Trigger wire release mechanism
WO2013078235A1 (en) 2011-11-23 2013-05-30 Broncus Medical Inc Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
WO2013096965A1 (en) 2011-12-22 2013-06-27 Dc Devices, Inc. Methods and devices for intra-atrial devices having selectable flow rates
AU2013212056B2 (en) 2012-01-25 2016-07-21 Intact Vascular, Inc. Endoluminal device and method
US8585635B2 (en) 2012-02-15 2013-11-19 Sequana Medical Ag Systems and methods for treating chronic liver failure based on peritoneal dialysis
CA2868341C (en) 2012-03-26 2021-01-12 Glaukos Corporation System and method for delivering multiple ocular implants
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
WO2013162724A1 (en) 2012-04-26 2013-10-31 Tryton Medical, Inc. Support for treating vascular bifurcations
US10952732B2 (en) 2013-02-21 2021-03-23 Boston Scientific Scimed Inc. Devices and methods for forming an anastomosis
EP3636164A1 (en) 2012-05-17 2020-04-15 Boston Scientific Scimed Inc. Devices for access across adjacent tissue layers
MX351261B (en) 2012-06-01 2017-10-06 Surmodics Inc Apparatus and method for coating balloon catheters.
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
US10512482B2 (en) 2012-10-05 2019-12-24 Board Of Regents Of The University Of Texas System System and method for scoring the left ventricular endocardium to increase left ventricular compliance
US11090468B2 (en) 2012-10-25 2021-08-17 Surmodics, Inc. Apparatus and methods for coating medical devices
EP2948104B1 (en) 2013-01-25 2019-07-24 Apica Cardiovascular Limited Systems for percutaneous access, stabilization and closure of organs
CN105188831B (en) 2013-03-14 2021-01-01 因特尔赛克特耳鼻喉公司 Systems, devices, and methods for treating sinus conditions
US9592151B2 (en) 2013-03-15 2017-03-14 Glaukos Corporation Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
US10517759B2 (en) 2013-03-15 2019-12-31 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
JP6302992B2 (en) 2013-03-15 2018-03-28 エーピーケー アドバンスド メディカル テクノロジーズ,インコーポレイテッド Connector for implantation into the tissue wall
EP2999412B1 (en) * 2013-05-21 2020-05-06 V-Wave Ltd. Apparatus for delivering devices for reducing left atrial pressure
WO2015031476A1 (en) 2013-08-27 2015-03-05 Board Of Regents, The University Of Texas System System and method for cutting trabeculae carneae of the left ventricle to increase lv compliance
EP3061424A4 (en) * 2013-10-25 2017-06-21 Olympus Corporation Medical stent
US10675450B2 (en) 2014-03-12 2020-06-09 Corvia Medical, Inc. Devices and methods for treating heart failure
US20150313595A1 (en) 2014-05-02 2015-11-05 W. L. Gore & Associates, Inc. Anastomosis Devices
US11712230B2 (en) 2014-05-02 2023-08-01 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US20150342875A1 (en) 2014-05-29 2015-12-03 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
WO2015187872A1 (en) 2014-06-04 2015-12-10 Cagent Vascular, Llc Cage for medical balloon
US10632292B2 (en) 2014-07-23 2020-04-28 Corvia Medical, Inc. Devices and methods for treating heart failure
US10485909B2 (en) 2014-10-31 2019-11-26 Thoratec Corporation Apical connectors and instruments for use in a heart wall
CA2969535A1 (en) 2014-11-03 2016-05-12 Cagent Vascular, Llc Serration balloon
US9375336B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
US9433520B2 (en) 2015-01-29 2016-09-06 Intact Vascular, Inc. Delivery device and method of delivery
US20170028176A1 (en) * 2015-07-27 2017-02-02 Treus Medical, Inc. Transluminal implant and methods and apparatus for loading, delivering, and deploying an implant
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US10166374B2 (en) 2015-09-17 2019-01-01 Cagent Vascular, Llc Wedge dissectors for a medical balloon
JP7145757B2 (en) 2015-10-12 2022-10-03 リフロー メディカル インコーポレイテッド Stents with protruding drug delivery features and related systems and methods
US10993824B2 (en) 2016-01-01 2021-05-04 Intact Vascular, Inc. Delivery device and method of delivery
US10085830B2 (en) * 2016-05-13 2018-10-02 Medos International Sarl Device, system, and method for delivery of a tissue fixation device
US10716922B2 (en) 2016-08-26 2020-07-21 Sequana Medical Nv Implantable fluid management system having clog resistant catheters, and methods of using same
JP7071338B2 (en) 2016-08-26 2022-05-18 セクアナ メディカル エヌブイ Systems and methods for managing and analyzing data generated by embedded devices
AU2017361422B2 (en) 2016-11-16 2023-07-06 Cagent Vascular, Inc. Systems and methods of depositing drug into tissue through serrations
GB201622215D0 (en) 2016-12-23 2017-02-08 Tonkin Liu Stents Ltd Expanding device
US11724075B2 (en) 2017-04-18 2023-08-15 W. L. Gore & Associates, Inc. Deployment constraining sheath that enables staged deployment by device section
EP3612246B1 (en) 2017-05-24 2020-12-30 Sequana Medical NV Direct sodium removal method, solution and apparatus to reduce fluid overload in heart failure patients
US11559618B2 (en) 2017-05-24 2023-01-24 Sequana Medical Nv Formulations and methods for direct sodium removal in patients having severe renal dysfunction
US11660218B2 (en) 2017-07-26 2023-05-30 Intact Vascular, Inc. Delivery device and method of delivery
US11116625B2 (en) 2017-09-28 2021-09-14 Glaukos Corporation Apparatus and method for controlling placement of intraocular implants
CN108095857A (en) * 2017-12-18 2018-06-01 上海脉全医疗器械有限公司 A kind of biodegradable stent system for crotch vascular lesion
US11744589B2 (en) 2018-01-20 2023-09-05 V-Wave Ltd. Devices and methods for providing passage between heart chambers
CN112739406A (en) 2018-07-25 2021-04-30 开金血管有限公司 Medical balloon catheter with enhanced pushability
US11628466B2 (en) 2018-11-29 2023-04-18 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
WO2020234751A1 (en) 2019-05-20 2020-11-26 V-Wave Ltd. Systems and methods for creating an interatrial shunt
WO2023199267A1 (en) 2022-04-14 2023-10-19 V-Wave Ltd. Interatrial shunt with expanded neck region

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290728B1 (en) * 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit

Family Cites Families (237)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876419A (en) 1976-10-02 1999-03-02 Navius Corporation Stent and method for making a stent
US4503568A (en) 1981-11-25 1985-03-12 New England Deaconess Hospital Small diameter vascular bypass and method
US6106538A (en) 1984-05-14 2000-08-22 Shiber; Samuel Method for forming an internal coronary bypass
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4769029A (en) 1987-06-19 1988-09-06 Patel Jayendrakumar I Prosthetic graft for arterial system repair
US5527337A (en) 1987-06-25 1996-06-18 Duke University Bioabsorbable stent and method of making the same
US4953553A (en) 1989-05-11 1990-09-04 Advanced Cardiovascular Systems, Inc. Pressure monitoring guidewire with a flexible distal portion
US6974475B1 (en) 1987-12-08 2005-12-13 Wall W Henry Angioplasty stent
US4995857A (en) 1989-04-07 1991-02-26 Arnold John R Left ventricular assist device and method for temporary and permanent procedures
US6004261A (en) 1989-04-28 1999-12-21 C. R. Bard, Inc. Formed-in-place endovascular stent and delivery system
US5609626A (en) 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
US5135467A (en) 1989-12-07 1992-08-04 Medtronic, Inc. Implantable system and method for coronary perfusions assistance
US5071407A (en) * 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member
US5344426A (en) 1990-04-25 1994-09-06 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
DK124690D0 (en) 1990-05-18 1990-05-18 Henning Rud Andersen FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5035702A (en) 1990-06-18 1991-07-30 Taheri Syde A Method and apparatus for providing an anastomosis
US5389096A (en) 1990-12-18 1995-02-14 Advanced Cardiovascular Systems System and method for percutaneous myocardial revascularization
US5193546A (en) 1991-05-15 1993-03-16 Alexander Shaknovich Coronary intravascular ultrasound imaging method and apparatus
US5304220A (en) 1991-07-03 1994-04-19 Maginot Thomas J Method and apparatus for implanting a graft prosthesis in the body of a patient
JPH07500023A (en) 1991-07-04 1995-01-05 オーエン、アール・ロナルド tubular surgical implant
CA2074304C (en) 1991-08-02 1996-11-26 Cyril J. Schweich, Jr. Drug delivery catheter
CA2087132A1 (en) 1992-01-31 1993-08-01 Michael S. Williams Stent capable of attachment within a body lumen
US5470320A (en) 1992-04-10 1995-11-28 Tiefenbrun; Jonathan Method and related device for obtaining access to a hollow organ
US5758663A (en) 1992-04-10 1998-06-02 Wilk; Peter J. Coronary artery by-pass method
US5385541A (en) 1992-04-24 1995-01-31 Loma Linda University Medical Center Cerebrospinal fluid shunt capable of minimal invasive revision
US5258008A (en) 1992-07-29 1993-11-02 Wilk Peter J Surgical stapling device and associated method
US5330486A (en) 1992-07-29 1994-07-19 Wilk Peter J Laparoscopic or endoscopic anastomosis technique and associated instruments
US5409019A (en) 1992-10-30 1995-04-25 Wilk; Peter J. Coronary artery by-pass method
US5429144A (en) 1992-10-30 1995-07-04 Wilk; Peter J. Coronary artery by-pass method
US5287861A (en) 1992-10-30 1994-02-22 Wilk Peter J Coronary artery by-pass method and associated catheter
US5578075B1 (en) 1992-11-04 2000-02-08 Daynke Res Inc Minimally invasive bioactivated endoprosthesis for vessel repair
US5256141A (en) 1992-12-22 1993-10-26 Nelson Gencheff Biological material deployment method and apparatus
US5797960A (en) * 1993-02-22 1998-08-25 Stevens; John H. Method and apparatus for thoracoscopic intracardiac procedures
US5384541A (en) 1993-03-05 1995-01-24 Hewlett-Packard Company Precision timed delay measurement using phaselocked CW technique
WO1994021196A2 (en) 1993-03-18 1994-09-29 C.R. Bard, Inc. Endovascular stents
AU689094B2 (en) 1993-04-22 1998-03-26 C.R. Bard Inc. Non-migrating vascular prosthesis and minimally invasive placement system therefor
US5441515A (en) 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US6159565A (en) 1993-08-18 2000-12-12 W. L. Gore & Associates, Inc. Thin-wall intraluminal graft
US5545209A (en) * 1993-09-30 1996-08-13 Texas Petrodet, Inc. Controlled deployment of a medical device
US5445646A (en) * 1993-10-22 1995-08-29 Scimed Lifesystems, Inc. Single layer hydraulic sheath stent delivery apparatus and method
DE69419877T2 (en) 1993-11-04 1999-12-16 Bard Inc C R Fixed vascular prosthesis
US5443497A (en) 1993-11-22 1995-08-22 The Johns Hopkins University Percutaneous prosthetic by-pass graft and method of use
US5423851A (en) 1994-03-06 1995-06-13 Samuels; Shaun L. W. Method and apparatus for affixing an endoluminal device to the walls of tubular structures within the body
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US6001123A (en) 1994-04-01 1999-12-14 Gore Enterprise Holdings Inc. Folding self-expandable intravascular stent-graft
US6152141A (en) 1994-07-28 2000-11-28 Heartport, Inc. Method for delivery of therapeutic agents to the heart
US5836965A (en) * 1994-10-19 1998-11-17 Jendersee; Brad Stent delivery and deployment method
US5976159A (en) 1995-02-24 1999-11-02 Heartport, Inc. Surgical clips and methods for tissue approximation
US5797933A (en) 1996-07-16 1998-08-25 Heartport, Inc. Coronary shunt and method of use
US5683449A (en) 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
CA2566929C (en) 1995-03-10 2009-04-21 Bard Peripheral Vascular, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5591197A (en) 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
US5571168A (en) 1995-04-05 1996-11-05 Scimed Lifesystems Inc Pull back stent delivery system
DE19514638C2 (en) 1995-04-20 1998-06-04 Peter Dr Med Boekstegers Device for the selective suction and retroinfusion of a fluid from or into body veins controlled by venous pressure
US6251104B1 (en) * 1995-05-10 2001-06-26 Eclipse Surgical Technologies, Inc. Guiding catheter system for ablating heart tissue
US5534007A (en) * 1995-05-18 1996-07-09 Scimed Life Systems, Inc. Stent deployment catheter with collapsible sheath
US5840059A (en) 1995-06-07 1998-11-24 Cardiogenesis Corporation Therapeutic and diagnostic agent delivery
JPH11507267A (en) 1995-06-07 1999-06-29 バクスター・インターナショナル・インコーポレイテッド Externally reinforced tape-reinforced vascular graft
US6224584B1 (en) * 1997-01-14 2001-05-01 Eclipse Surgical Technologies, Inc. Therapeutic and diagnostic agent delivery
US6010530A (en) 1995-06-07 2000-01-04 Boston Scientific Technology, Inc. Self-expanding endoluminal prosthesis
US5762631A (en) * 1995-07-14 1998-06-09 Localmed, Inc. Method and system for reduced friction introduction of coaxial catheters
FR2737404B1 (en) * 1995-08-03 1997-09-19 Braun Celsa Sa PROSTHESIS IMPLANTABLE IN A HUMAN OR ANIMAL CONDUCT, SUCH AS A WALL Expander, OR ANEURISM PROSTHESIS
EP0955933B1 (en) 1995-10-13 2009-08-26 Medtronic Vascular, Inc. A device for interstitial transvascular intervention
US6726677B1 (en) * 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters
DE69633411T2 (en) * 1995-10-13 2005-10-20 Transvascular, Inc., Menlo Park METHOD AND DEVICE FOR PREVENTING ARTERIAL ATTRACTIONS AND / OR FOR CARRYING OUT OTHER TRANSVASCULAR INTERVENTIONS
US6375615B1 (en) 1995-10-13 2002-04-23 Transvascular, Inc. Tissue penetrating catheters having integral imaging transducers and their methods of use
US6283983B1 (en) 1995-10-13 2001-09-04 Transvascular, Inc. Percutaneous in-situ coronary bypass method and apparatus
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US5865723A (en) 1995-12-29 1999-02-02 Ramus Medical Technologies Method and apparatus for forming vascular prostheses
DK0955950T3 (en) 1996-01-04 2006-07-31 Timothy A M Dr Chuter Flat Wire Stent
JP3882015B2 (en) 1996-01-19 2007-02-14 ボストン サイエンティフィック サイムド, インコーポレイテッド Increased radius curve catheter
US5938682A (en) 1996-01-26 1999-08-17 Cordis Corporation Axially flexible stent
US5980553A (en) 1996-12-20 1999-11-09 Cordis Corporation Axially flexible stent
AU733341B2 (en) * 1996-02-02 2001-05-10 Transvascular, Inc. A device, system and method for interstitial transvascular intervention
US6709444B1 (en) * 1996-02-02 2004-03-23 Transvascular, Inc. Methods for bypassing total or near-total obstructions in arteries or other anatomical conduits
WO1997027898A1 (en) * 1996-02-02 1997-08-07 Transvascular, Inc. Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
US5810836A (en) 1996-03-04 1998-09-22 Myocardial Stents, Inc. Device and method for trans myocardial revascularization (TMR)
US5843163A (en) 1996-06-06 1998-12-01 Wall; William H. Expandable stent having radioactive treatment means
US6007544A (en) 1996-06-14 1999-12-28 Beth Israel Deaconess Medical Center Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US5676670A (en) * 1996-06-14 1997-10-14 Beth Israel Deaconess Medical Center Catheter apparatus and method for creating a vascular bypass in-vivo
US5662124A (en) 1996-06-19 1997-09-02 Wilk Patent Development Corp. Coronary artery by-pass method
US6569147B1 (en) * 1996-07-26 2003-05-27 Kensey Nash Corporation Systems and methods of use for delivering beneficial agents for revascularizing stenotic bypass grafts and other occluded blood vessels and for other purposes
US6080170A (en) * 1996-07-26 2000-06-27 Kensey Nash Corporation System and method of use for revascularizing stenotic bypass grafts and other occluded blood vessels
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5755682A (en) 1996-08-13 1998-05-26 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
US6007543A (en) 1996-08-23 1999-12-28 Scimed Life Systems, Inc. Stent delivery system with stent securement means
CA2213015A1 (en) 1996-08-23 1998-02-23 Arterial Vascular Engineering, Inc. A profiled stent and method of manufacture
US5655548A (en) 1996-09-16 1997-08-12 Circulation, Inc. Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion
US6186972B1 (en) 1996-09-16 2001-02-13 James A. Nelson Methods and apparatus for treating ischemic heart disease by providing transvenous myocardial perfusion
US6447539B1 (en) 1996-09-16 2002-09-10 Transvascular, Inc. Method and apparatus for treating ischemic heart disease by providing transvenous myocardial perfusion
US6293955B1 (en) 1996-09-20 2001-09-25 Converge Medical, Inc. Percutaneous bypass graft and securing system
US6379319B1 (en) 1996-10-11 2002-04-30 Transvascular, Inc. Systems and methods for directing and snaring guidewires
US6432127B1 (en) 1996-10-11 2002-08-13 Transvascular, Inc. Devices for forming and/or maintaining connections between adjacent anatomical conduits
US20020029079A1 (en) 1996-10-11 2002-03-07 Transvascular, Inc. Devices for forming and/or maintaining connections between adjacent anatomical conduits
US5968093A (en) 1996-10-28 1999-10-19 Biotronik Mess-And Therapiegerate Gmbh & Co. Stent
US6258119B1 (en) 1996-11-07 2001-07-10 Myocardial Stents, Inc. Implant device for trans myocardial revascularization
US5971993A (en) * 1996-11-07 1999-10-26 Myocardial Stents, Inc. System for delivery of a trans myocardial device to a heart wall
US6053924A (en) 1996-11-07 2000-04-25 Hussein; Hany Device and method for trans myocardial revascularization
US6042581A (en) 1996-11-08 2000-03-28 Thomas J. Fogarty Transvascular TMR device and method
US5910150A (en) 1996-12-02 1999-06-08 Angiotrax, Inc. Apparatus for performing surgery
US5925074A (en) 1996-12-03 1999-07-20 Atrium Medical Corporation Vascular endoprosthesis and method
US5807384A (en) 1996-12-20 1998-09-15 Eclipse Surgical Technologies, Inc. Transmyocardial revascularization (TMR) enhanced treatment for coronary artery disease
US6067988A (en) 1996-12-26 2000-05-30 Eclipse Surgical Technologies, Inc. Method for creation of drug delivery and/or stimulation pockets in myocardium
US5999678A (en) 1996-12-27 1999-12-07 Eclipse Surgical Technologies, Inc. Laser delivery means adapted for drug delivery
US5925012A (en) 1996-12-27 1999-07-20 Eclipse Surgical Technologies, Inc. Laser assisted drug delivery
US20040088042A1 (en) * 1997-01-31 2004-05-06 Transvascular, Inc. Devices for forming and/or maintaining connections between adjacent anatomical conduits
US5980551A (en) * 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
US5968064A (en) 1997-02-28 1999-10-19 Lumend, Inc. Catheter system for treating a vascular occlusion
US6217549B1 (en) * 1997-02-28 2001-04-17 Lumend, Inc. Methods and apparatus for treating vascular occlusions
US6010449A (en) 1997-02-28 2000-01-04 Lumend, Inc. Intravascular catheter system for treating a vascular occlusion
US6508825B1 (en) * 1997-02-28 2003-01-21 Lumend, Inc. Apparatus for treating vascular occlusions
US6026814A (en) * 1997-03-06 2000-02-22 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
US6045565A (en) 1997-11-04 2000-04-04 Scimed Life Systems, Inc. Percutaneous myocardial revascularization growth factor mediums and method
US6035856A (en) * 1997-03-06 2000-03-14 Scimed Life Systems Percutaneous bypass with branching vessel
US5938632A (en) 1997-03-06 1999-08-17 Scimed Life Systems, Inc. Radiofrequency transmyocardial revascularization apparatus and method
US6093177A (en) * 1997-03-07 2000-07-25 Cardiogenesis Corporation Catheter with flexible intermediate section
US5851232A (en) 1997-03-15 1998-12-22 Lois; William A. Venous stent
US5853419A (en) * 1997-03-17 1998-12-29 Surface Genesis, Inc. Stent
US5876373A (en) 1997-04-04 1999-03-02 Eclipse Surgical Technologies, Inc. Steerable catheter
AU744343B2 (en) 1997-04-11 2002-02-21 Transvascular, Inc. Methods and apparatus for transmyocardial direct coronary revascularization
US6162245A (en) 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
US5855597A (en) 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US6245102B1 (en) * 1997-05-07 2001-06-12 Iowa-India Investments Company Ltd. Stent, stent graft and stent valve
CN1321619C (en) 1997-05-08 2007-06-20 C·R·巴德有限公司 TMT stent and delivery system
DE29708879U1 (en) 1997-05-20 1997-07-31 Jomed Implantate Gmbh Coronary stent
US6007575A (en) 1997-06-06 1999-12-28 Samuels; Shaun Laurence Wilkie Inflatable intraluminal stent and method for affixing same within the human body
EP0890346A1 (en) 1997-06-13 1999-01-13 Gary J. Becker Expandable intraluminal endoprosthesis
US6213126B1 (en) * 1997-06-19 2001-04-10 Scimed Life Systems, Inc. Percutaneous artery to artery bypass using heart tissue as a portion of a bypass conduit
US6071292A (en) 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US5935119A (en) 1997-08-06 1999-08-10 United States Surgical Corporation Perfusion structure
IT1293973B1 (en) 1997-08-13 1999-03-15 Sorin Biomedica Cardio Spa ELEMENT FOR ANCHORING OF INSTALLATION DEVICES IN SITU.
US5908029A (en) 1997-08-15 1999-06-01 Heartstent Corporation Coronary artery bypass with reverse flow
US6046934A (en) 1999-01-12 2000-04-04 Macronix International Co., Ltd. Method and device for multi-level programming of a memory cell
US5984965A (en) 1997-08-28 1999-11-16 Urosurge, Inc. Anti-reflux reinforced stent
US5922022A (en) 1997-09-04 1999-07-13 Kensey Nash Corporation Bifurcated connector system for coronary bypass grafts and methods of use
US5984955A (en) 1997-09-11 1999-11-16 Wisselink; Willem System and method for endoluminal grafting of bifurcated or branched vessels
US5976181A (en) 1997-09-22 1999-11-02 Ave Connaught Balloon mounted stent and method therefor
US6565594B1 (en) * 1997-09-24 2003-05-20 Atrium Medical Corporation Tunneling device
US6520988B1 (en) 1997-09-24 2003-02-18 Medtronic Ave, Inc. Endolumenal prosthesis and method of use in bifurcation regions of body lumens
US5976182A (en) 1997-10-03 1999-11-02 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent and method of loading the same
US5984956A (en) 1997-10-06 1999-11-16 Heartstent Corporation Transmyocardial implant
US6102941A (en) 1997-10-06 2000-08-15 Heartstent Corporation Transmyocardial implant with coronary ingrowth
US5980548A (en) * 1997-10-29 1999-11-09 Kensey Nash Corporation Transmyocardial revascularization system
US5989207A (en) 1997-11-03 1999-11-23 Hughes; Boyd R. Double swirl stent
US6056743A (en) * 1997-11-04 2000-05-02 Scimed Life Systems, Inc. Percutaneous myocardial revascularization device and method
US6183432B1 (en) * 1997-11-13 2001-02-06 Lumend, Inc. Guidewire and catheter with rotating and reciprocating symmetrical or asymmetrical distal tip
US6330884B1 (en) * 1997-11-14 2001-12-18 Transvascular, Inc. Deformable scaffolding multicellular stent
US5961548A (en) 1997-11-18 1999-10-05 Shmulewitz; Ascher Bifurcated two-part graft and methods of implantation
US5976169A (en) 1997-12-16 1999-11-02 Cardiovasc, Inc. Stent with silver coating and method
US6251418B1 (en) * 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
US6197324B1 (en) * 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
US6217527B1 (en) * 1998-09-30 2001-04-17 Lumend, Inc. Methods and apparatus for crossing vascular occlusions
US6231546B1 (en) * 1998-01-13 2001-05-15 Lumend, Inc. Methods and apparatus for crossing total occlusions in blood vessels
US6081738A (en) * 1998-01-15 2000-06-27 Lumend, Inc. Method and apparatus for the guided bypass of coronary occlusions
US6015405A (en) 1998-01-20 2000-01-18 Tricardia, L.L.C. Device for forming holes in tissue
US6214041B1 (en) 1998-01-20 2001-04-10 Heartstent Corporation Transmyocardial implant with septal perfusion
US6250305B1 (en) 1998-01-20 2001-06-26 Heartstent Corporation Method for using a flexible transmyocardial implant
US6200311B1 (en) * 1998-01-20 2001-03-13 Eclipse Surgical Technologies, Inc. Minimally invasive TMR device
US6193734B1 (en) * 1998-01-23 2001-02-27 Heartport, Inc. System for performing vascular anastomoses
US6007576A (en) 1998-02-06 1999-12-28 Mcclellan; Scott B. End to side anastomic implant
US6651670B2 (en) 1998-02-13 2003-11-25 Ventrica, Inc. Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
US20020144696A1 (en) 1998-02-13 2002-10-10 A. Adam Sharkawy Conduits for use in placing a target vessel in fluid communication with a source of blood
WO1999040868A1 (en) 1998-02-13 1999-08-19 Ventrica, Inc. Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US6808498B2 (en) 1998-02-13 2004-10-26 Ventrica, Inc. Placing a guide member into a heart chamber through a coronary vessel and delivering devices for placing the coronary vessel in communication with the heart chamber
US20010041902A1 (en) 1998-02-13 2001-11-15 Michael J. Lynch Anastomotic methods and devices for placing a target vessel in fluid communication with a source of blood
US6095997A (en) 1998-03-04 2000-08-01 Corvascular, Inc. Intraluminal shunt and methods of use
US6093185A (en) * 1998-03-05 2000-07-25 Scimed Life Systems, Inc. Expandable PMR device and method
US5935162A (en) 1998-03-16 1999-08-10 Medtronic, Inc. Wire-tubular hybrid stent
US6561998B1 (en) * 1998-04-07 2003-05-13 Transvascular, Inc. Transluminal devices, systems and methods for enlarging interstitial penetration tracts
US5980566A (en) 1998-04-11 1999-11-09 Alt; Eckhard Vascular and endoluminal stents with iridium oxide coating
US6029672A (en) 1998-04-20 2000-02-29 Heartstent Corporation Transmyocardial implant procedure and tools
US6076529A (en) * 1998-04-20 2000-06-20 Heartstent Corporation Transmyocardial implant with inserted vessel
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
DE19819629A1 (en) 1998-05-04 1999-11-11 Jomed Implantate Gmbh Radially expandable stent
US5989287A (en) 1998-05-06 1999-11-23 Av Healing Llc Vascular graft assemblies and methods for implanting same
US6352554B2 (en) 1998-05-08 2002-03-05 Sulzer Vascutek Limited Prosthetic tubular aortic conduit and method for manufacturing the same
US20010027287A1 (en) 1998-05-26 2001-10-04 Trans Vascular, Inc. Apparatus for providing coronary retroperfusion and/or left ventricular assist and methods of use
US6066169A (en) 1998-06-02 2000-05-23 Ave Connaught Expandable stent having articulated connecting rods
US5980533A (en) 1998-06-09 1999-11-09 Scimed Life Systems, Inc. Stent delivery system
US6113823A (en) 1998-06-09 2000-09-05 Heartstent Corporation Pyrolytic carbon transmyocardial implant
US6306125B1 (en) 1998-06-22 2001-10-23 Neovasys, Inc. Angiogenic implant delivery system and method
US6036697A (en) * 1998-07-09 2000-03-14 Scimed Life Systems, Inc. Balloon catheter with balloon inflation at distal end of balloon
US6171251B1 (en) * 1998-07-14 2001-01-09 Eclipse Surgical Technologies, Inc. Method and apparatus for optimizing direct vessel implants for myocardial revascularization
DE19836253C1 (en) * 1998-08-11 1999-12-23 Goldschmidt Ag Th Polymethacrylate-polyalkylene oxide block copolymers, useful as dispersants and compatibilisers in printing ink, paint and plastics formulations
US6053942A (en) * 1998-08-18 2000-04-25 Heartstent Corporation Transmyocardial implant with coronary stent
US6406488B1 (en) * 1998-08-27 2002-06-18 Heartstent Corporation Healing transmyocardial implant
US6139541A (en) 1998-09-02 2000-10-31 Heartstent Corporation Guide for transmyocardial implant
NO984144L (en) * 1998-09-09 2000-03-10 Carmeda Ab Composition comprising heparin as a non-thrombogenic surface coating
US6196230B1 (en) 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
EP1112043B1 (en) 1998-09-10 2006-04-05 Percardia, Inc. Tmr shunt
WO2000015147A1 (en) 1998-09-10 2000-03-23 Percardia, Inc. Transmycardial shunt and its attachment mechanism, for left ventricular revascularization
US6261304B1 (en) 1998-09-10 2001-07-17 Percardia, Inc. Delivery methods for left ventricular conduit
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6197050B1 (en) 1998-09-14 2001-03-06 Heartstent Corporation Transmyocardial implant with compliance collar
US5997563A (en) 1998-09-28 1999-12-07 Medtronic, Inc. Implantable stent having variable diameter
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6432126B1 (en) * 1998-09-30 2002-08-13 C.R. Bard, Inc. Flexible vascular inducing implants
US6283935B1 (en) * 1998-09-30 2001-09-04 Hearten Medical Ultrasonic device for providing reversible tissue damage to heart muscle
US6251079B1 (en) * 1998-09-30 2001-06-26 C. R. Bard, Inc. Transthoracic drug delivery device
US6248112B1 (en) * 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6363938B2 (en) 1998-12-22 2002-04-02 Angiotrax, Inc. Methods and apparatus for perfusing tissue and/or stimulating revascularization and tissue growth
EP1027870B1 (en) 1999-01-12 2005-03-30 Orbus Medical Technologies, Inc. Expandable intraluminal endoprosthesis
EP1020166A1 (en) 1999-01-12 2000-07-19 Orbus Medical Technologies, Inc. Expandable intraluminal endoprosthesis
US6187034B1 (en) * 1999-01-13 2001-02-13 John J. Frantzen Segmented stent for flexible stent delivery system
AU2851000A (en) 1999-01-15 2000-08-01 Ventrica, Inc. Methods and devices for forming vascular anastomoses
US7025773B2 (en) 1999-01-15 2006-04-11 Medtronic, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US6193726B1 (en) 1999-01-15 2001-02-27 Heartstent Corporation Insertion tool for transmyocardial implant
EP1020878B1 (en) 1999-01-18 2003-11-19 Matsushita Electric Industrial Co., Ltd. High electric resistance magnetic film
US6395208B1 (en) * 1999-01-25 2002-05-28 Atrium Medical Corporation Method of making an expandable fluoropolymer device
US6110201A (en) 1999-02-18 2000-08-29 Venpro Bifurcated biological pulmonary valved conduit
US6217575B1 (en) * 1999-02-24 2001-04-17 Scimed Life Systems, Inc. PMR catheter
US6231551B1 (en) * 1999-03-01 2001-05-15 Coaxia, Inc. Partial aortic occlusion devices and methods for cerebral perfusion augmentation
US5976155A (en) 1999-03-05 1999-11-02 Advanced Cardiovascular Systems, Inc. System for removably securing a stent on a catheter assembly and method of use
US6569145B1 (en) * 1999-03-25 2003-05-27 Transvascular, Inc. Pressure-controlled continuous coronary sinus occlusion device and methods of use
US6258117B1 (en) * 1999-04-15 2001-07-10 Mayo Foundation For Medical Education And Research Multi-section stent
US20040044392A1 (en) * 1999-05-03 2004-03-04 Jomed Gmbh Stent catheter system
US6409697B2 (en) 1999-05-04 2002-06-25 Heartstent Corporation Transmyocardial implant with forward flow bias
US6406491B1 (en) 1999-05-04 2002-06-18 Heartstent Corporation Compliant transmyocardial implant
US6565528B1 (en) * 1999-05-07 2003-05-20 Scimed Life Systems, Inc. Apparatus and method for delivering therapeutic and diagnostic agents
US6182668B1 (en) 1999-05-13 2001-02-06 Heartstent Corporation Transmyocardial implant with induced tissue flap
US7285235B2 (en) * 1999-05-19 2007-10-23 Medtronic, Inc. Manufacturing conduits for use in placing a target vessel in fluid communication with a source of blood
US6719805B1 (en) * 1999-06-09 2004-04-13 C. R. Bard, Inc. Devices and methods for treating tissue
US6126649A (en) 1999-06-10 2000-10-03 Transvascular, Inc. Steerable catheter with external guidewire as catheter tip deflector
US20040058097A1 (en) * 1999-06-11 2004-03-25 Weder Donald E. Curled or crimped decorative grass having an optical effect
US7892246B2 (en) * 1999-07-28 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting conduits and closing openings in tissue
US6251116B1 (en) * 1999-07-28 2001-06-26 Vasconnect, Inc. Device for interconnecting vessels in a patient
US6302892B1 (en) 1999-08-04 2001-10-16 Percardia, Inc. Blood flow conduit delivery system and method of use
US6253768B1 (en) * 1999-08-04 2001-07-03 Percardia, Inc. Vascular graft bypass
US6638237B1 (en) * 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
US6113630A (en) * 1999-08-13 2000-09-05 Heartstent Corporation Transmyocardial implant with minimized coronary insertion
USD438618S1 (en) 1999-08-27 2001-03-06 Jan Otto Solem Graft connector
US6525323B1 (en) * 2000-04-18 2003-02-25 Koninklijke Philips Electronics, N.V. Method and apparatus for improved estimation of characteristics of pulses detected by a nuclear camera
DE10161823A1 (en) * 2001-12-15 2003-06-26 Tigra Hartstoff Gmbh Cylinder head drill or similar tool with hard metal cutting
US6672932B1 (en) * 2002-01-14 2004-01-06 Treasure Bay, Inc. Actuatable toy containing deformable bladder

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290728B1 (en) * 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
US7101402B2 (en) * 1998-09-10 2006-09-05 Percardia, Inc. Designs for left ventricular conduit

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040186507A1 (en) * 1998-09-10 2004-09-23 Percardia, Inc. Stent delivery system and method of use
US7704222B2 (en) 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US7736327B2 (en) 1998-09-10 2010-06-15 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8216174B2 (en) 1998-09-10 2012-07-10 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8597226B2 (en) 1998-09-10 2013-12-03 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US20030212413A1 (en) * 1999-08-04 2003-11-13 Percardia, Inc. Blood flow conduit delivery system and method of use
US20030220661A1 (en) * 2002-05-21 2003-11-27 Heartstent Corporation Transmyocardial implant delivery system
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
EP2111243A4 (en) * 2006-11-09 2014-07-02 Corlife Ohg Cardiovascular procedures
EP2111243A2 (en) * 2006-11-09 2009-10-28 Contract Medical International Gmbh Cardiovascular procedures
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11154398B2 (en) 2008-02-26 2021-10-26 JenaValve Technology. Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry

Also Published As

Publication number Publication date
US20030105514A1 (en) 2003-06-05
US6290728B1 (en) 2001-09-18
US6610100B2 (en) 2003-08-26
US20050004505A1 (en) 2005-01-06
US7347867B2 (en) 2008-03-25
US20010053932A1 (en) 2001-12-20
US7101402B2 (en) 2006-09-05
US20030195458A1 (en) 2003-10-16
US6953481B2 (en) 2005-10-11

Similar Documents

Publication Publication Date Title
US6610100B2 (en) Designs for left ventricular conduit
US8187217B2 (en) TMR shunt
US10299791B2 (en) Endovascular aneurysm repair system
US6605113B2 (en) Vascular graft bypass
US20080262602A1 (en) Methods and conduits for flowing blood from a heart chamber to a blood vessel
US20100114306A1 (en) Cardiovascular procedures
CA2381192A1 (en) Methods and apparatus for direct coronary revascularization

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION